# The endolysosomal system in conventional and unconventional protein secretion

Eloïse Néel, Marioara Chiritoiu-Butnaru, William Fargues, Morgane Denus, Maëlle Colladant, Aurore Filaquier, Sarah E Stewart, Sylvain Lehmann, Chiara Zurzolo, David C Rubinsztein, et al.

<figure><img src="image_1.png" /></figure>

► To cite this version:

Eloïse Néel, Marioara Chiritoiu-Butnaru, William Fargues, Morgane Denus, Maëlle Colladant, et al. The endolysosomal system in conventional and unconventional protein secretion. Journal of Cell Biology, 2024, 223 (9), pp.e202404152. 10.1083/jcb.202404152. hal-04671364

HAL Id: hal-04671364

https://hal.science/hal-04671364v1

Submitted on 14 Aug 2024

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>
# The endolysosomal system in conventional and unconventional protein secretion

Eloïse Néel<fnref n="1" />* , Marioara Chiritoiu-Butnaru²* , William Fargues<fnref n="1" /> , Morgane Denus<fnref n="1" /> , Maëlle Colladant<fnref n="1" /> , Aurore Filaquier<fnref n="1" /> , Sarah E. Stewart³ , Sylvain Lehmann⁴ , Chiara Zurzolo⁵ , David C. Rubinsztein⁶,⁷ , Philippe Marin<fnref n="1" /> , Marie-Laure Parmentier<fnref n="1" /> , and Julien Villeneuve<fnref n="1" />

Most secreted proteins are transported through the “conventional” endoplasmic reticulum–Golgi apparatus exocytic route for their delivery to the cell surface and release into the extracellular space. Nonetheless, formative discoveries have underscored the existence of alternative or “unconventional” secretory routes, which play a crucial role in exporting a diverse array of cytosolic proteins outside the cell in response to intrinsic demands, external cues, and environmental changes. In this context, lysosomes emerge as dynamic organelles positioned at the crossroads of multiple intracellular trafficking pathways, endowed with the capacity to fuse with the plasma membrane and recognized for their key role in both conventional and unconventional protein secretion. The recent recognition of lysosomal transport and exocytosis in the unconventional secretion of cargo proteins provides new and promising insights into our understanding of numerous physiological processes.

## Introduction

Our understanding of the basic machinery governing intra-
cellular transport via the conventional endoplasmic reticulum
(ER)-Golgi secretory pathway has recently been expanded by
discoveries highlighting alternative mechanisms that drive
secretion. These unconventional secretory routes involve
multiple cellular processes facilitating the active and selective
release of cytosolic proteins lacking an N-terminal signal
sequence for ER entry (Filaquier et al., 2022; Zhang and
Schekman, 2013). Unexpectedly, lysosomes have emerged as
multifaceted intracellular compartments where specific cargo
proteins, with or without N-terminal signal sequence, can
converge before being released into the extracellular space by
lysosomal exocytosis (Tancini et al., 2020; Filaquier et al.,
2022).

The diverse array of lysosomal functions relies on the coop-
eration of an extensive repertoire of molecular factors, including
luminal hydrolases, integral lysosomal membrane proteins
(LMPs), and lysosome-associated proteins. Approximately 60
acid hydrolases are actively involved in the degradation and
recycling of macromolecules delivered to lysosomes, and ~120
LMPs sustain other lysosome properties, such as acidification,

nutrient and ion transport, protein import from the cytosol, and
lysosome fusion and interactions with other intracellular com-
partments. In addition, lysosome-associated proteins are dy-
namically recruited from the cytosol to the lysosomal surface,
making lysosomes central hubs for nutrient and nucleic acid
sensing and platforms for multiple trafficking and signaling
pathways critical for regulating energy metabolism and adapt-
ing to cellular stress (Chapel et al., 2013; Ballabio and Bonifacino,
2020; Perera and Zoncu, 2016). Thus, lysosomes are no longer
only considered as terminal degradative organelles but as ver-
satile compartments with diverse functions essential for the
maintenance of cellular homeostasis (Hämälistö et al., 2024;
Roney et al., 2022). Furthermore, lysosomes are highly dy-
namic organelles that can fuse with the plasma membrane
(PM) and thereby release their contents into the extracellular
milieu, contributing for instance to PM integrity, extracellu-
lar matrix (ECM) remodeling, and defense against pathogens
(Tancini et al., 2020; Blott and Griffiths, 2002; Andrews,
2000; Villeneuve et al., 2018).

A notable feature of lysosomes is their unique position at the
intersection of various intracellular trafficking pathways, in-
cluding autophagic, endocytic, and biosynthetic secretory routes

Correspondence to Julien Villeneuve: julien.villeneuve@igf.cnrs.fr

*E. Néel and M. Chiritoiu-Butnaru share joint first authorship.

© 2024 Néel et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).

<footnote n="1">¹Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France; ²Institute of Biochemistry of the Romanian Academy, Bucharest, Romania; ³Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia; ⁴Laboratoire de Biochimie-Protéomique Clinique-Plateforme de Protéomique Clinique, Université de Montpellier, Institute for Regenerative Medicine and Biotherapy Centre Hospitalier Universitaire de Montpellier, Institute for Neurosciences of Montpellier INSERM, Montpellier, France; ⁵Unité de Trafic Membranaire et Pathogenèse, Institut Pasteur, UMR3691 CNRS, Paris, France; ⁶Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK; ⁷UK Dementia Research Institute, Cambridge, UK.</footnote>
<figure><img src="image_3.png" /></figure>

**Figure 1.** Lysosomes are at the crossroad of several intracellular trafficking pathways. Newly synthesized lysosomal hydrolases and LMPs contain an N-terminal hydrophobic signal sequence or transmembrane domains that allow their targeting and insertion into the ER. Once transported through the Golgi apparatus, lysosomal proteins are then subjected to post-translational modifications including the addition of mannose-6-phosphate (M6P) residues. M6P residues are essential for protein sorting at the TGN, where lysosomal proteins are packaged into clathrin-coated intermediates and diverted from the biosynthetic secretory pathway to the endocytic pathway for delivery to lysosomes. Post-Golgi clathrin-coated carriers are mainly targeted directly to the endolysosomal pathway (Polishchuk et al., 2006). This pathway relies on coordinated membrane fluxes involving organelle maturation and membrane fission/fusion events (Huotari and Helenius, 2011). In addition to the well-characterized direct transport to lysosomes, several newly synthesized LMPs follow an indirect pathway. This pathway entails the transport of LMPs to the PM, their subsequent internalization into early endosomes, and delivery to LEs and lysosomes (Braun et al., 1989). By combining innovative methods like the "retention using selective hooks" system with high-resolution live-cell imaging, studies revealed the spatiotemporal dynamics of these distinct pathways (Chen et al., 2017). The development of pooled genome-wide CRISPR screens designed to identify factors involved in protein transport and secretion holds promise for addressing these crucial issues (Bassaganyas et al., 2019; Popa et al., 2019). In addition to functional factors and extracellular substrates transported to lysosomes via the secretory and endocytic pathways, cytoplasmic material is targeted to lysosomes through sequestration by macroautophagy. In the autophagic process, cytoplasmic substrates are initially sequestered within a cup-shaped double membrane structure known as the phagophore, which upon expansion and complete closure forms the autophagosome. Autophagosomes are then transported along the microtubules and ultimately fuse with lysosomes (Bento et al., 2016). Along the endocytic and autophagic pathways, the fusion of lysosomes with LE/MVBs and autophagosomes forms endolysosomes and autolysosomes, respectively. From these hybrid compartments, lysosomes or terminal/storage lysosomes are reformed via lysosomal regeneration cycles, through processes of tubulation, maturation, and content condensation (Yang and Wang, 2021). In this review, the terms "lysosomes," "endolysosomes," or "LE/lysosomes" are used alternatively due to uncertainty in the cited references regarding the exact nature of the described organelles. Illustration created with Biorender.

(Fig. 1). These intricate interconnections, coupled with the dynamic nature of lysosomes and their exocytic capabilities, endow this organelle with essential roles in the secretion of cargo proteins transported by both conventional and unconventional secretory routes. In this review, we will explore emerging evidence establishing lysosomes as central trafficking stations in various secretory pathways and examine how lysosomal properties can be modulated converting lysosomes into secretory compartments.

**Lysosomes as transport carriers for both conventional and unconventional protein secretion**

**Lysosomes are transport carriers for the secretion of signal sequence-containing cargo proteins**

In eukaryotes, most secreted and PM proteins follow the conventional secretory pathway in which they are first targeted and inserted into the ER membrane via their N-terminal hydrophobic signal sequences or transmembrane domains (Rapoport, 2007). Then, proteins progress through the Golgi apparatus and
are subsequently transported from the trans-Golgi network (TGN) to the PM (Schekman, 2008). A distinction is commonly made between constitutive and regulated secretion. Constitutive secretion relies on transport carriers that continuously shuttle from the TGN to the PM, yet their diversity and biogenesis mechanisms remain insufficiently understood (Chen et al., 2017; De Matteis and Luini, 2008; Stalder and Gershlick, 2020). This process occurs in most cell types and contributes to the release of enzymes, growth factors, and ECM components, among others (Parchure and von Blume, 2023; Holcomb et al., 1988; Bossard et al., 2007). In regulated secretion, cargo proteins are sorted at the TGN into specialized secretory granules that fuse with the PM in a controlled manner upon stimulation by external factors. This process is characteristic of specialized cell types such as pancreatic β cells, endothelial cells, intestinal goblet cells, and neuroendocrine cells, to rapidly mobilize and export insulin, von Willebrand factor, mucin, and chromogranin, respectively (Burgoyne and Morgan, 2003; Davis and Dickey, 2008; Bauerfeind and Huttner, 1993).

In addition to post-Golgi carriers involved in constitutive and regulated secretion, it is now established that lysosomes derived from the endocytic system (Fig. 1) can also fuse with the PM and release their contents into the extracellular milieu (Andrews, 2000; Tancini et al., 2020). Lysosomal exocytosis triggered by external cues was initially thought to be restricted to cell type-specific organelles known as specialized lysosomes or lysosome-related organelles (LROs). These were identified on the basis of compositional and physiological features shared with standard degradative lysosomes. LROs include lytic granules in cytotoxic T lymphocytes and natural killer cells (Blott and Griffiths, 2002), major histocompatibility complex class II compartments in macrophages, dendritic cells, and B lymphocytes (Harding, 1996); basophil granules in basophils and mast cells (Schwartz and Austen, 1980); azurophil granules in neutrophils (Kjeldsen et al., 1993); dense granules in blood platelets (Van Oost et al., 1985); and melanosomes in melanocytes (Orlow, 1995). Reminiscent of standard degradative lysosomes, these organelles are acidic compartments with membranes derived primarily from the endocytic system. Most LROs contain enzymes and LMPs essential for substrate degradation and recycling. They also package newly synthesized secreted proteins based on their specialized biological function. Similar to standard lysosomes, structural and functional factors delivered to specialized lysosomes are transported through the ER-Golgi secretory pathway, either directly or indirectly after recognizing a tyrosine or dileucine-based signal in the amino acid sequence of cargoes or cargo receptors (Dell'Angelica et al., 2000). While both standard and specialized lysosomes coexist in some cell types, such as in melanocytes and blood platelets, lytic granules are the major lysosomal structures in cytotoxic T lymphocytes (Luzio et al., 2014). In this context, it is important to distinguish lysosomes and specialized lysosomes from other structures containing electron-dense proteins, often referred to as LROs. One example is Weibel-Palade bodies in endothelial cells, which directly originate from the TGN but not from the endocytic pathway, in contrast with standard and specialized lysosomes (Raposo et al., 2007). The close relationship between

standard and specialized lysosomes is underscored by observations in some human autosomal recessive disorders, such as Chediak-Higashi, Hermansky-Pudlak, and Griscelli's syndromes, which share common clinical features, including varying degrees of hypopigmentation due to impaired melanosome secretion, prolonged bleeding due to defects in dense granule secretion by blood platelets, and immunologic deficiencies due to impaired secretion of various granules by immune cells (Bowman et al., 2019; Bonifacino, 2004). At the cellular level, patients with Chediak-Higashi syndrome exhibit abnormal morphology and numbers of lysosomes and LROs (De Chadarévian, 2011; Durchfort et al., 2012). These genetic disorders, characterized by defects in the biogenesis of both standard and specialized lysosomes and governed by numerous common molecular determinants, further support the common organellar lineage of these structures.

In addition to LROs, the presence of lysosomes, which exhibit exocytosis, was then recognized not only in lower eukaryotes, such as Dictyostelium discoideum, Leishmania donovani, and Tetrahymena pyriformis (Dimond et al., 1981; Gottlieb and Dwyer, 1981; Müller, 1972), but also in various cell types from higher eukaryotes and humans, including hepatocytes and pancreatic acinar cells, which release lysosomal hydrolases to promote digestion, and osteoclasts to promote bone resorption (LeSage et al., 1993; Mostov and Werb, 1997; Gross et al., 1985). In cancer cells, the release of lysosomal hydrolases promotes tumorigenesis, invasion, and metastasis (Bian et al., 2016; Sevenich and Joyce, 2014).

Subsequently, regulated exocytosis of lysosomes has been observed in most cell types. In particular, studies indicate that an increase in intracellular Ca²⁺ concentration triggers lysosomal exocytosis in a temperature- and ATP-dependent manner in fibroblasts, epithelial cells, and myoblasts. In these experiments, lysosomal exocytosis was monitored by the release of fluid phase tracers previously loaded into lysosomes, the increased expression of cell surface LMPs, and the release of lysosomal enzymes, such as the processed form of cathepsin D (Rodríguez et al., 1997; Andrews, 2000). Similar to the Ca²⁺-regulated exocytosis of post-Golgi secretory granules in specialized secretory cells, lysosomal exocytosis represents a ubiquitous form of Ca²⁺-regulated exocytosis. Further studies have revealed that sequential Ca²⁺-regulated lysosomal exocytosis and massive endocytosis cooperate to maintain PM integrity in wounded cells (Reddy et al., 2001; Jaiswal et al., 2002; Hilgemann et al., 2013). In addition to providing the endomembrane necessary for PM resealing, lysosomal exocytosis also mobilizes lysosomal hydrolases to the cell surface, playing a critical role in PM repair. For example, acid sphingomyelinase, released by lysosomal exocytosis, can convert sphingomyelin to ceramide on the outer leaflet of the PM. These ceramide-enriched domains on the cell surface promote lipid bilayer invagination and rapid endosome formation, contributing to the removal of PM lesions (Tam et al., 2010; Schuchman, 2010). Other secreted lysosomal cysteine proteases have been implicated in this process by facilitating acid sphingomyelinase access to the PM through ECM degradation (Castro-Gomes et al., 2016).

In summary, similar to post-Golgi carriers, lysosomes also behave as secretory vesicles that fuse with the PM and release
<figure><img src="image_4.png" /><figcaption>**Figure 2.** **Conventional and unconventional protein secretion.** (A) Proteins with a signal peptide reach their final destination (the extracellular space, the PM, or lysosomes) after transport along the conventional or biosynthetic secretory pathway. Briefly, cargo proteins are inserted into the ER via the SEC61 channel-forming translocon complex and then sorted by the use of COPII-coated vesicles to reach the Golgi apparatus. At the level of the trans-Golgi network, constitutive secretory proteins such as growth factors and ECM components are packaged into constitutive vesicles, whereas specific proteins such as insulin and mucin are packaged into secretory granules according to cell type. Structural and functional lysosomal proteins are packaged into clathrin-coated vesicles and transported to the endolysosomal system. Specialized lysosomes or LROs and standard lysosomes can then behave as secretory vesicles, releasing cargo proteins containing a signal sequence as post-Golgi carriers. (B) Proteins without a signal peptide can be secreted via unconventional protein secretion (UcPS), independent of the conventional secretory pathway. In type I and II UcPS, cytosolic proteins are secreted by direct translocation across the PM through protein channels and ABC transporters, respectively. In type III UcPS, cargo proteins are incorporated into membrane intermediates through protein channels (orange) or membrane remodeling (yellow) that define multiple entry gates along the biosynthetic secretory, endocytic, or autophagic pathways. In type IV UcPS, integral membrane proteins located in the ER are transported to the PM independently of the Golgi apparatus. CMA: Chaperone-mediated autophagy; EE: Early endosome; ERGIC: Endoplasmic reticulum–Golgi intermediate compartment; LE: Late endosome; MAPS: Misfolded-associated protein secretion; MVB: Multivesicular body; THU: TMED10-channeled UcPS. The figure was created with Biorender.</figcaption></figure>

their contents into the extracellular milieu in a regulated manner (Fig. 2 A). This underscores the critical role of lysosomes as organelles that regulate diverse cellular and physiological functions, including metabolism, innate and adaptive immunity, thrombosis and hemostasis, ECM remodeling, maintenance of PM integrity, and cell survival.

**Lysosomes are transport carriers for the unconventional secretion of cargo proteins lacking a signal sequence**

An increasing number of cytosolic proteins lacking a signal sequence for ER entry have been shown to be actively and selectively exported from eukaryotic cells. Remarkably, this process is independent of the highly conserved ER-Golgi secretory pathway. Protein families transported via unconventional secretory pathways include inflammatory cytokines, annexins,

heat shock proteins, lipid chaperones, antioxidant enzymes, and misfolded proteins, among others (Rabouille, 2017; Zhang and Schekman, 2013; Filaquier et al., 2022). In recent years, there has been extensive documentation of the extracellular functions of these proteins and the impact of disrupting their secretion in various diseases (Cao et al., 2013; Radisky et al., 2009; Sitia and Rubartelli, 2020). Despite the identification of numerous alternative routes for the export of cytosolic proteins, the molecular trafficking machinery remains poorly understood in most cases (Fig. 2 B). In type I unconventional protein secretion (UcPS), cargo proteins are directly translocated across the PM. Proposed mechanisms include the formation of pores by gasdermin D for the release of interleukin-1β (IL-1β) in macrophages (Evavold et al., 2018), or the formation of pores through the oligomerization of fibroblast growth factor-2 (FGF-2), followed by its
insertion into the PM, a necessary step for its secretion (Steringer et al., 2017). As with FGF-2 secretion, self-translocation has been reported for HIV-Tat secretion (Zeitler et al., 2015). Lipidated proteins, such as the farnesylated pheromone m- and α-factors in yeast, are also directly translocated across the PM. In this case, translocation is facilitated by ATP-binding cassette (ABC) transporters, and they are referred to as type II UcPS cargoes (Rabouille et al., 2012). In addition to type I and II UcPS, cytosolic proteins can be secreted into the extracellular milieu after transport through intermediate compartments derived from autophagic membranes, endosomes, multivesicular bodies (MVBs), or lysosomes that release their contents after exocytosis. This form of transport, termed type III UcPS, involves multiple membranes and protein trafficking pathways (Rabouille, 2017; Zhang and Schekman, 2013; Filaquier et al., 2022). Given the unique position of lysosomes at the intersection of multiple intracellular trafficking pathways, as discussed below, cytosolic cargo proteins trafficked by type III UcPS may converge to lysosomes before their release into the extracellular space (Fig. 2 B). In type IV UcPS or Golgi bypass, observed under conditions such as ER stress or after inhibition of the conventional secretory pathway, integral membrane proteins located in the ER are transported to the PM independently of the Golgi apparatus (Gee et al., 2018) (Fig. 2 B).

**Membrane remodeling for type III UcPS.** In type III UcPS, cytosolic material and cargo proteins can be incorporated into intermediate compartments through membrane remodeling. Autophagy allows the engulfment and sequestration of cytosolic material via autophagosome biogenesis. Genetic studies, initially performed in yeast and subsequently extended to mammalian cells, have shown that evolutionarily conserved autophagy-related genes (ATG) are required for the secretion of cytoplasmic substrates. These include the acyl-CoA-binding protein Acb1, inflammatory mediators, toxic protein aggregates or aggregation-prone proteins, and bacterial and viral pathogens (Duran et al., 2010; Dupont et al., 2011; Ejlerskov et al., 2013; Gerstenmaier et al., 2015). While the concept of secretory autophagy has recently gained attention, the direct involvement of autophagosomes in UcPS has not been clearly established. Autophagosomes have been proposed to deviate from their usual fusion with lysosomes and instead directly fuse with the PM in response to lysosomal damage. This rerouting was hypothesized to occur through the mobilization of dedicated soluble N-ethylmaleimide-sensitive-factor attachment protein receptors (SNAREs), in combination with a specialized tripartite motif containing (TRIM) cargo receptor (Kimura et al., 2017). Although several studies indicate that the ATG gene-dependent UcPS involves cytosolic cargo surrounded by an LC3-positive double membrane structure, a hallmark of autophagosomes, there is no conclusive evidence for direct fusion of autophagosomes with the PM (Dupont et al., 2011; Zhang et al., 2015; Ejlerskov et al., 2013). Instead, it is conceivable that autophagosomes might fuse with downstream membrane intermediates such as MVBs or lysosomes, which subsequently release their contents into the extracellular milieu after exocytosis (Ejlerskov et al., 2013; Baixuli et al., 2014; Takenouchi et al., 2009; Jeppesen et al., 2019). Alternatively, the autophagy machinery may intersect and influence other protein trafficking pathways and secretion events, as recently reviewed (Deretic et al., 2012; Levine and Kroemer, 2019; New and Thomas,

2019). For example, autophagy-deficient osteoclasts and mast cells exhibit altered secretion of lysosomal contents, leading to impaired bone resorption and compromised immune responses, respectively (DeSelm et al., 2011; Ushio et al., 2011). Also, while ATG-related proteins may be required for the early stages of the biogenesis of compartments for unconventional secretion (CUPS) in yeast, it is crucial to note that CUPS, which are critical for Acb1 secretion, are distinct from autophagosomes (Cruz-Garcia et al., 2014; Curwin et al., 2016). Whether autophagosomes can fuse directly with the PM or whether they act as vesicular intermediates that fuse with downstream vesicular compartments (e.g., MVBs or lysosomes) remains to be elucidated.

Another known membrane remodeling pathway for type III UcPS is via extracellular vesicles. These vesicles can be shed from the PM (known as microvesicles or ectosomes) or generated within the endolysosomal system (known as exosomes) (Meldolesi, 2022). Within the endolysosomal system, cytosolic proteins are sequestered by inward invagination of the membrane in late endosome (LE), followed by the budding and release of small vesicles into the lumen of the organelle, to ultimately form MVBs (Klumperman and Raposo, 2014; Frankel and Audhya, 2018). The endosomal sorting complex required for transport proteins plays a key role in this process (Remec Pavlin and Hurley, 2020). The resulting MVBs can then fuse with the PM, leading to the release of exosomes into the extracellular milieu. A critical process appears to be the conversion of phosphatidylinositol-3-phosphate (PI(3)P) to PI(4)P on the membrane of MVBs, which promotes the recruitment of the exocyst that directs MVBs for fusion with the PM (Liu et al., 2023). Alternatively, in adipocytes and B cells, exosomes formed along the endolysosomal pathway can also be released by lysosomal exocytosis and contribute to adipogenesis (Kim et al., 2019) and adaptive immune responses (Hämälistö et al., 2024), respectively.

**Protein translocation for type III UcPS.** In addition to pathways involving membrane remodeling to engulf cytosolic material, in type III UcPS, cargo proteins can also be translocated from the cytosol into intermediate compartments by dedicated transporters or channels.

A well-recognized mechanism for the selective degradation of intracellular components is chaperone-mediated autophagy (CMA), which enables the delivery of cytosolic proteins to the lysosomal surface and their subsequent translocation into the lysosomal lumen. In CMA, substrate recognition selectivity is mediated by a canonical KFERQ-like motif found in ~40% of proteins in the mammalian proteome (Dice, 1990). In addition, posttranslational modifications, including phosphorylation or acetylation, modify the properties of alternative residues that contribute to the generation of this signal recognition motif or facilitate conformational changes that expose or mask this pen-tapeptide motif (Kaushik and Cuervo, 2016, 2018; Quintavalle et al., 2014). In CMA, the cytosolic chaperone HSC70 directly binds to the KFERQ-like motif and targets the protein to lysosomes (Chiang et al., 1989). It has been proposed that substrate translocation into lysosomes is mediated by the multimerization of LAMP2A, forming a 700 kDa translocation protein complex (Bandyopadhyay et al., 2010). However, whether LAMP2A forms a conducting channel for translocation remains to be confirmed
by means of structural analysis and in vitro reconstitution approaches. Initially characterized as a selective degradation pathway critical for protein quality control, CMA has also been implicated in the presentation of cytoplasmic autoantigens at the cell surface (Zhou et al., 2005). In addition, studies suggest that IL-1β, which has three KFERQ-like motifs in its amino acid sequence, may be released from cells after translocation into lysosomes by a mechanism similar to CMA (Andrei et al., 1999; Zhang et al., 2015; Semino et al., 2018; Sitia and Rubartelli, 2020).

Unlike CMA, a process known as misfolded-associated protein secretion (MAPS) facilitates the translocation of misfolded cytosolic proteins into LE/lysosomes, followed by their exocytosis, when other protein quality control pathways, such as proteasomal degradation, fail to prevent excessive accumulation of aberrant polypeptides. Notable substrates for MAPS include cytosolic proteins associated with neurodegenerative diseases, such as Tau, ataxin-3, TDP43, and α-synuclein (Fontaine et al., 2016; Ye, 2018; Lee et al., 2016, 2018; Xu et al., 2018). When expressed in HEK293T cells, these misfolded-prone proteins are recognized by the ER-associated deubiquitinase USP19 and subsequently transferred to a complex formed by the chaperone HSC70 and its co-chaperone DnaJ heat shock protein member C5 (DNAJC5), which is anchored to endolysosomal compartments after palmitoylation (Xu et al., 2018; Wu et al., 2023; Lee et al., 2018). The function of DNAJC5 in α-synuclein UCP5 was recently reconstituted in a variety of cells, including neurons, demonstrating the critical role of palmitoylated DNAJC5 in high-order oligomeric forms in α-synuclein UCP5 (Wu et al., 2023). This study also reported that DNAJC5, together with α-synuclein, localizes and is translocated into the endolysosomal compartments, which presumably represent intermediates in α-synuclein secretion. In line with these observations, the authors also showed that bafilomycin A1, a lysosomal ATPase inhibitor known to promote secretion of MVBs and lysosomal contents (Cashikar and Hanson, 2019; Tapper and Sundler, 1995), promotes α-synuclein secretion. Of particular interest, the secreted α-synuclein mediated by palmitoylated DNAJC5 oligomers is mainly released into the extracellular space as soluble monomeric forms not enclosed within extracellular vesicles, whereas DNAJC5 is present in both soluble and extracellular vesicle-bound forms. The translocation machinery responsible for the transfer of misfolded proteins during MAPS has not been identified but does not appear to involve LAMP2A, as seen in CMA. The subsequent fusion of vesicular intermediates with the PM has been shown to be promoted by the SNAREs VAMP7, VAMP8, and SNAP-23, leading to the release of misfolded proteins from the cell (Ye, 2018; Fontaine et al., 2016; Lee et al., 2016, 2018). A recent study suggested that instead of using mainly endolysosomal compartments as vesicular intermediates, substrates exported from cells through the MAPS pathway and in a DNAJC5-dependent manner may be trafficked through an alternative vesicular intermediate (Lee et al., 2023). This compartment, located in the perinuclear area, near the Golgi apparatus, would be the equivalent of CUPS, identified in yeast as a critical compartment for UCP5 (Lee et al., 2022). However, its exact nature and whether it is formed from Golgi and endosomal membranes like CUPS in yeast remains to be elucidated. It will also be important to establish whether these

different vesicular intermediates, e.g., endolysosomes or CUPS, can be differentially mobilized for secretion of MAPS substrates, depending on cellular stress or experimental culture conditions. Although MAPS and CMA share common features, such as the involvement of chaperones that target cytosolic proteins to the LE-lysosomal compartment for translocation, these two pathways also exhibit important differences. In contrast to CMA, cargo recognition in MAPS is not mediated by a specific pentapeptide motif, but rather relies on exposed hydrophobic segments that characterize the misfolded state of protein substrates. Furthermore, as mentioned above, protein translocation into LE/lysosomes in MAPS does not require LAMP2 or cargo unfolding, in contrast to CMA (Lee et al., 2018; Ye, 2018). By exporting misfolded cytosolic proteins to the extracellular milieu using LE lysosomes as transport carriers, the MAPS pathway provides an additional protein quality control essential for maintaining homeostasis during proteotoxic stress.

It is likely that additional transporters or protein channels that facilitate cargo translocation, present at various membrane intermediates converging toward secretory compartments, remain to be uncovered and fully characterized. A recent study identified a novel protein translocation pathway called THU (TMED10-channeled UCP5) and demonstrated its ability to allow the entry of multiple cytosolic cargos into vesicular intermediates for UCP5 (Zhang et al., 2020). The proposed model relies on the oligomerization of the transmembrane emp24 domain-containing protein 10 (TMED10) to form a channel that facilitates the translocation of cargo proteins into a specialized subcompartment of the ER-Golgi intermediate compartment (ERGIC) under the control of the small GTPases Rab1A, Rab1B, and Rab2A (Sun et al., 2024). The ERGIC has been proposed to play a role in autophagosome biogenesis through a non-classical type of COPII vesicle (Ge et al., 2013, 2017, 2014; Li et al., 2022). The THU pathway might thus cooperate with the autophagosome/endolysosomal compartments to achieve secretion. The THU pathway appears to be dependent on cytosolic cargo unfolding and is promoted by HSP90 chaperones (Zhang et al., 2020). More recently, studies have also demonstrated the involvement of TMED10-mediated UCP5 in the secretion of IL-33, which plays a role in regulating intestinal epithelial differentiation and central nervous system homeostasis (Wang et al., 2024; Jiao et al., 2024). Another study reported that the UCP5 of mutant huntingtin (Htt) is a multistep process including (1) the incorporation of Htt into the ERGIC by TMED10; (2) the transport of Htt through the autophagic pathway; and (3) its targeting to lysosomes, which then undergo exocytosis, leading to the release of Htt into the extracellular space (Ahat et al., 2022). In this series of events, GRASP55, a critical factor involved in various UCP5 pathways (Bruns et al., 2011; Chiritoiu et al., 2019), appears to be essential in stabilizing the TMED10 channel and facilitating the autophagosome-lysosome fusion (Ahat et al., 2022). While TMED10 appears to play a critical role in the transport of cytosolic proteins into membrane intermediates during UCP5, structural analyses and cell-free reconstitution approaches are required to unambiguously consider TMED10 as a translocation channel. In addition to cargo proteins trafficked through the THU pathway, fatty acid binding protein-4 (FABP4)
has recently been added to the growing list of cytosolic proteins that undergo UcPS. FABP4 secretion by adipocytes is independent of autophagosome and exosome biogenesis but requires sequential trafficking through endosomes and lysosomes (Villeneuve et al., 2018). However, the mechanisms and machinery involved in FABP4 translocation from the cytosol to the endosomal lumen remain to be characterized. Lastly, studies have reported that cytosolic HSP70, aldo-keto reductase family-1-member B8 (AKR1B8), and AKR1B10 can be released into the extracellular milieu after their translocation from the cytosol to LE/lysosomes via ABC transporters. Pharmacological inhibition of these transporters using glibenclamide, a non-specific ABC transporter inhibitor, or more selective inhibitors such as 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and bromosulfalein, resulted in a reduction of HSP70, AKR1B8, and AKR1B10 secretion, and of the release of markers of lysosomal exocytosis (Andrei et al., 1999; Mambula and Calderwood, 2006; Luo et al., 2011; Tang et al., 2014).

Collectively, these studies support the concept that in type III UcPS, cargo proteins can be incorporated into different intracellular compartments either by membrane remodeling and engulfment of the cytosol, as observed in autophagy and during the formation of intraluminal vesicles, or by protein channel-mediated translocation, as exemplified by pathways such as CMA, MAPS, or THU (Chiritoiu-Butnaru et al., 2022; Filaquier et al., 2022). Although several membrane-bound compartments appear to fulfill the role of vesicular intermediates capable of fusing with the PM in UcPS, a predominant point of convergence for the diverse routes recruiting cytosolic cargo proteins appears to be the LE/lysosomes (Fig. 2 B), highly dynamic organelles with exocytosis properties.

## Mechanisms and regulatory elements that control lysosome dynamics and exocytosis

Lysosomes, which range from 50 to 200 per cell, exhibit a non-uniform distribution throughout the cytosol. They also display significant heterogeneity in terms of dynamics, size, shape, intraluminal pH, and interactions with other intracellular compartments (Ballabio and Bonifacino, 2020). Furthermore, lysosomes are positioned at the crossroads of various trafficking pathways responsible for the transport of diverse substrates/cargoes, as well as specific structural and functional factors. Taken together, this implies that distinct lysosomal subpopulations may be specialized for specific functions, with their proportions dynamically adjusted in response to metabolic status, stress conditions, or external signals. In this context, a critical question arises: how can a degradative organelle be redirected for fusion with the PM for exocytosis? In other words, what makes a lysosome a secretory compartment? To answer succinctly, lysosomes must first relocate to the cell periphery, where they subsequently dock and fuse with the PM. This sequence of events involves numerous factors that induce profound changes in lysosomal properties.

### Lysosome positioning and motility

In most cell types, lysosomes are predominantly concentrated in the perinuclear region, near the Golgi apparatus, and around the microtube-organizing center. This positioning is orchestrated by retrograde lysosomal transport along microtubules, a process

mediated by dynein motor proteins associated with dynactin (Burkhardt et al., 1997). The recruitment of dynein-dynactin to lysosomes involves the small GTPase Rab7, under the control of the GTPase-activating proteins TBC1D15 and TBC1D2, along with the guanine-nucleotide-exchange factor complex Mon1-Ccz1 (Frasa et al., 2010; Zhang et al., 2005; Nordmann et al., 2010). The Rab7-interacting lysosomal protein (RILP) and the cholesterol sensor OSBP-related protein 1L (ORP1L) have also been implicated in lysosome coupling to dynein-dynactin (Johansson et al., 2007; Progida et al., 2007). Conversely, the relocation of lysosomes to the cell periphery, a prerequisite for their exocytosis, is facilitated by anterograde lysosomal transport along microtubules via kinesin motor proteins (Hirokawa and Noda, 2008). Several kinesins, including the kinesin-1 proteins KIF5A, KIF5B, and KIF5C; the kinesin-2 protein KIF3; the kinesin-3 proteins KIF1A and KIF1B; and the kinesin-13 protein KIF2, participate in the anterograde transport of lysosomes (Pu et al., 2016). Kinesins interact directly with microtubules via a globular motor domain and with specific adaptors and cargos via a tail domain, facilitating their lysosomal binding and tracking. The mechanisms that couple kinesins to lysosomes are well characterized for specific kinesins. For example, kinesin-1 are recruited to lysosomes by the cooperative interaction of the multisubunit BLOC-1-related complex, the small GTPase Arl8 and its effectors Sif1, and the kinesin-interacting protein PLEKHM2 (Balderhaar and Ungermann, 2013; Pu et al., 2015). In addition, a variety of regulatory factors, including several Rab proteins, transmembrane lysosomal proteins such as LAMP1, LAMP2, or TMEM106B, intricately control the spatial distribution and bidirectional movement of lysosomes in conjunction with various factors or processes such as Ca²⁺ efflux from lysosomes, lipid composition of their membrane, intraluminal pH, organelle contact, and the actin cytoskeleton (Pu et al., 2016; Tancini et al., 2020; Buratta et al., 2020). Lysosome positioning and mobility within the cytoplasm are finely regulated in response to various perturbations, including changes in the metabolic status of the cell. Under conditions of nutrient depletion, lysosomes tend to cluster near the nucleus, facilitating fusion with autophagosomes, whereas nutrient availability promotes lysosomal movement toward the cell periphery (Korolchuk et al., 2011; Pu et al., 2016). In addition, in the context of proteotoxic stress, such as the accumulation of aggregation-prone proteins like α-synuclein, lysosomes containing these proteins relocate to the cell periphery, thereby becoming less acidic and losing their degradative properties (Dilsizoglu Senol et al., 2021).

### Lysosomal intraluminal pH

Lysosomal intraluminal pH is a critical parameter that profoundly affects lysosomal properties and exocytosis. Lysosomes are characterized by a highly acidic pH (4.5-5.0), which is optimal for the activity of most luminal lysosomal hydrolases involved in the degradation of various macromolecules. Interestingly, the cellular location of lysosomes has been shown to determine their intraluminal pH, with peripheral lysosomes exhibiting lower acidity and reduced degradative capacity (Johnson et al., 2016), potentially facilitating exocytosis (Andrei et al., 1999; Tapper and Sundler, 1995; Miao et al., 2015), compared with those located in
the perinuclear region, which are more acidic and have higher degradative activity (Johnson et al., 2016). A possible explanation for this heterogeneity in intraluminal pH may reflect the stabilization of the vacuolar H+ ATPase (V-ATPase) by RILP, the Rab7-interacting lysosomal protein, which promotes lysosome location in the perinuclear region. Consequently, RILP contributes to the maintenance of acidic pH in juxtanuclear lysosomes compared with peripheral lysosomes (Johnson et al., 2016). Accordingly, inhibition of lysosomal acidification by pharmacological agents such as bafilomycin A1, a lysosomal V-ATPase inhibitor, stimulates lysosome fusion with the PM and the subsequent release of their contents into the extracellular milieu (Tapper and Sundler, 1995). Likewise, disruption of the lysosomal pH by lysosomotropic drugs such as ammonium chloride or chloroquine also increases the exocytosis of LE/lysosomes (Brown et al., 1985; Alvarez-Erviti et al., 2011). Collectively, these studies support the notion that a less acidic endolysosomal environment with compromised degradative activity is important for redirecting these organelles toward secretory function.

### Lysosome contacts with other intracellular compartments

In addition to their fusion with endosomes, autophagosomes, and the PM, lysosomes establish physical interactions through membrane contact sites (MCS) with various intracellular compartments, including the Golgi apparatus, the ER, mitochondria, and peroxisomes. These contacts/interactions play a pivotal role in sustaining interorganellar communication and profoundly influence lysosome properties, such as their intraluminal pH, motility, and positioning. For example, during nutrient starvation, the protein RILP bridges the lysosome-associated protein folliculin with the Golgi-associated small GTPase Rab34, promoting the perinuclear clustering of lysosomes (Starling et al., 2016), where lysosome-autophagosome fusion is facilitated (Korolchuk et al., 2011). The maintenance of the perinuclear population of endolysosomes is also facilitated by MCS between endolysosomes and the ER, mediated by the sorting nexin-19 (SNX19). SNX19, a transmembrane protein localized in the ER, tethers endolysosomes by interacting with the phosphoinositide PI(3)P on the endolysosomal membrane (Saric et al., 2021). In addition, PI(3)P associated with Rab7 on the endolysosomal membrane interacts with the ER-anchored protein protrudin (Raiborg et al., 2015). Other factors involved in ER-endolysosome interactions include RNF26, an ER-anchored ubiquitin ligase that facilitates the recruitment and ubiquitination of the cytosolic protein SQSTM1. Ubiquitinated SQSTM1 can then bind to the ubiquitin-binding domain of the adaptor proteins EPS15 and TAX1BP1, which are localized to the endolysosomal surface (Jongsma et al., 2016). VAMP-associated protein (VAP) is another ER-tethering factor, which interacts with the endolysosomal cholesterol-sensing protein ORP1L (Rocha et al., 2009). In addition to regulating lysosome motility and positioning, these interactions with ER membranes allow Ca²⁺ delivery from the ER to lysosomes, a process mediated by the clustering of inositol 1,4,5-triphosphate receptors at the ER-lysosome MCS (Atakpa et al., 2018). They also facilitate the non-vesicular transfer of lipids, such as phospholipids and cholesterol, between these organelles (Luo et al., 2017; Kumar et al., 2018). Lysosome-mitochondria and

lysosome-peroxisome MCS are also critical in regulating the transfer of metabolites between these organelles and modulating lysosome dynamics (Leisten et al., 2023; Cisneros et al., 2022; Jin et al., 2015).

### Lysosome fusion with the PM

Under various stress conditions or in response to specific cellular demands, a subset of lysosomes with reduced acidity and degradative capacity, located proximal to the PM or translocated to the cell periphery, or lacking MCS with other intracellular compartments, can be mobilized for exocytosis. This process, which relies on the docking and fusion of lysosomes with the PM, is orchestrated by specific factors and specialized fusion machinery.

The docking of lysosomes to the outer leaflet of the PM occurs through the formation of a trans-SNARE complex involving the vesicle (v)-SNARE VAMP7 located on the lysosomal surface, and the target (t)-SNARE syntaxin-4 and synaptosome-associated protein of 23 kDa on the PM (Proux-Gillardeaux et al., 2007; Rao et al., 2004). Subsequently, lysosome-PM fusion is triggered by a local increase in intracellular Ca²⁺ levels, facilitated by the lysosomes themselves, which serve as Ca²⁺ reservoirs. Calcium efflux from lysosomes is mediated by the membrane protein mucolipin 1 (MCOLN1 or transient receptor potential mucolipin 1), which acts as a lysosomal Ca²⁺ channel. Calcium release from lysosomes binds to the Ca²⁺ sensor synaptotagmin VII (sytVII), which contains two C2 Ca²⁺-binding domains. This binding promotes the association of sytVII with preassembled trans-SNARE complexes and PM phospholipids, thereby facilitating lysosome fusion with the PM (Martinez et al., 2000). Interestingly, oxidative stress and reactive oxygen species have been shown to stimulate MCOLN1 activation, thereby facilitating Ca²⁺ release from lysosomes and subsequent exocytosis (Funato et al., 2020). Key regulators of this process include the small GTPases Rab3a and Rab10, which coordinate lysosomal docking at the PM for secretion (Vieira, 2018). In an inflammatory context, cytokines such as TNF-α promote lysosomal exocytosis, thereby facilitating α-synuclein propagation, an effect mediated by the involvement of the small GTPase Rab27A (Bae et al., 2022). Additionally, lysosomal structural proteins such as LAMP1 play a key role in lysosomal exocytosis. Sialylation of the N-terminal domain of LAMP1 facing the lysosomal lumen is critical. Knockdown of the sialidase N-acetyl-α-neuraminidase (Neu1) in mice enhances lysosomal recruitment and docking at the PM. Silencing LAMP1 reverses this phenotype, underscoring the importance of Neu1-controlled sialylation of LAMP1 in lysosomal exocytosis (Yogalingam et al., 2008). A study demonstrating that glucosylceramide accumulation within lysosomes induced by β-glucocerebrosidase inhibition enhances lysosomal exocytosis (Lunghi et al., 2022) also suggests that the lipid composition of lysosomes is a key determinant of their exocytosis.

### Concluding remarks and future perspectives

Located at the crossroads of multiple intracellular trafficking pathways, lysosomes are emerging as versatile organelles involved in diverse cellular functions that are critical for maintaining cellular homeostasis and adapting to stress conditions
(Perera and Zoncu, 2016). In addition to their role as regulatory hubs for signaling, metabolism, and quality control, lysosomes exhibit remarkable capabilities in exocytosis, which is essential for the release of various cargo proteins. Consequently, they also play essential roles in intercellular communication, PM repair, ECM remodeling, and clearance of harmful materials independent of degradative mechanisms (Tancini et al., 2020; Reddy et al., 2001; Villeneuve et al., 2018; Filaquier et al., 2022). Recent advances have expanded our understanding of how cargo proteins converge to lysosomes, underscoring the critical role of lysosomes as sorting stations for both conventional and unconventional secretion pathways (Tancini et al., 2020; Filaquier et al., 2022). Elucidating the intricate pathways and molecular players involved in these processes, along with the various cargoes trafficked through lysosomes and subsequently released via exocytosis, is of paramount importance. An important objective in the field of UcPS will also be to decipher how cargo proteins can be differentially targeted to specific or multiples UcPS pathways depending on the pathophysiological conditions, cellular stress, and cell types. The establishment of standard in vitro cell-based assays as well as relevant in vivo models will be crucial to address this important issue in the near future.

Lysosomal functions rely on coordinated processes involving the activation, recruitment, and transport of diverse molecular factors to lysosomes that shape their content, positioning, dynamics, interactions, and fusion with other organelles. The complex interplay between different lysosomal properties delineates their multifaceted roles as degradative, signaling, or secretory organelles. Importantly, these lysosomal properties are not mutually exclusive, but exhibit profound interdependencies that orchestrate lysosomal functions toward specific cellular outcomes. Different cellular demands or stress conditions can regulate or alter lysosomal functionality. For instance, disruptions in trafficking along the ER-Golgi secretory axis, as evidenced in pathological contexts such as cancer or pathogen infection (Banerjee et al., 2023; Chen et al., 2022), may affect the delivery of essential structural and functional components to lysosomes, including the V-ATPase or degradative enzymes. Similarly, the accumulation of excessive or deleterious materials within lysosomes, as observed in lysosomal storage disorders or neurodegenerative diseases can lead to lysosomal membrane permeabilization (Walkley and Vanier, 2009; Piovesana et al., 2023; Rose et al., 2023, Preprint), resulting in stressed lysosomes and a vicious cycle that compromises their intraluminal pH, catabolic properties, interactions with organelles, dynamics, and positioning. This can affect lysosomal content and induce lysosomal remodeling through the activation of both transcriptional and post-transcriptional programs (Perera and Zoncu, 2016; Zoncu and Perera, 2022). Thus, numerous interrelated events triggered in response to cellular nutritional status, stress conditions, or physiological demands differentially regulate lysosomal properties, potentially contributing to make a subset of secretion-competent lysosomes (Fig. 3). Therefore, unravelling the subtle interplay and functional relationship between lysosome properties and identifying molecular effectors and regulatory elements that act as molecular switches to convert lysosomes into secretory compartments are critical areas of investigation.

An important challenge is also to understand the mechanisms governing lysosomal heterogeneity within individual cells, and the mobilization of subpopulations of lysosomes for specific functions. It is worth noting that the lysosomal population includes autolysosomes, endolysosomes, and terminal/storage lysosomes, which coexist in a dynamic equilibrium intricately linked to the lysosomal regeneration cycle (Bright et al., 1997, 2016). During this cycle, terminal/storage lysosomes are reformed from autolysosomes and endolysosomes through processes such as tubulation, maturation, and content condensation (Yang and Wang, 2021). Remarkably, terminal/storage lysosomes exhibit reduced acidity and degradative activity compared with endolysosomes (Bright et al., 2016). Accordingly, the lysosomal regeneration cycle introduces an additional level of complexity to the heterogeneity of the lysosomal population, where nutritional, signaling, and stress cues can modulate lysosome properties to redirect this compartment toward secretion. Whether lysosomes undergoing secretion are also degradation competent, or whether the acquisition of secretory properties is detrimental to other lysosomal functions, remain important questions that warrant further exploration.

In addition to unraveling fundamental processes that govern lysosomal biology, the dissection of the molecular mechanisms that support the conversion of lysosomes into secretory organelles will also provide opportunities for the development of new therapeutic strategies in several diseases. Indeed, dysfunctional lysosomal degradation is a pathological hallmark of lysosomal storage disorders (Walkley and Vanier, 2009; Platt et al., 2018) and neurodegenerative diseases such as Parkinson's and Alzheimer's diseases (Fleming et al., 2022), which are characterized by the accumulation of harmful undigested substrates and misfolded proteins, respectively. Several studies have demonstrated that enhancing cellular clearance through lysosomal exocytosis can mitigate the deleterious accumulation of toxic material (Tsunemi et al., 2019; Xu et al., 2020; Medina et al., 2011; Spampanato et al., 2013). In these studies, lysosomal exocytosis was triggered either by a Ca²⁺ channel agonist (Tsunemi et al., 2019), or by activation of a specific transcriptional program controlled by the transcription factor EB (TFEB) (Xu et al., 2020; Medina et al., 2011; Spampanato et al., 2013), whose nuclear-cytoplasmic shuttling is regulated by mechanistic target of rapamycin complex 1 (mTORC1) (Roczniaki-Ferguson et al., 2012; Settembre et al., 2012; Takla et al., 2023). TFEB orchestrates the transcriptional expression of numerous genes involved in autophagy and lysosome biogenesis (Martina et al., 2012; Settembre et al., 2011). It also upregulates the expression of the lysosomal Ca²⁺ channel MCOLN1, facilitating lysosome fusion with the PM and release of lysosomal contents into the extracellular milieu (Xu et al., 2020; Medina et al., 2011). However, the concept that the conversion of lysosomes into secretory compartments represents an alternative to degradation processes, particularly in neurodegenerative diseases, warrants careful consideration. Studies suggest that the release of toxic misfolded proteins such as Tau and α-synuclein, while beneficial to the cells in which they accumulate, may have detrimental effects at the organismal level, by promoting the propagation of toxic protein species and disease progression in
<figure><img src="image_5.png" /></figure>

JCB

<figure><img src="image_6.png" /><figcaption>Figure 3. **Functional relationship between lysosomal properties.** Lysosomes are multifaceted organelles primarily known for their degradative properties sustained by structural and functional lysosomal proteins including, among others, LAMP1, LAMP2, and several hydrolases, such as Cathepsin D and L. The</figcaption></figure>
optimal activity of luminal hydrolyses is ensured by the acidic intraluminal pH of lysosomes (between 4.5 and 5.5) established by the vacuolar H⁺ APTase (v-ATPase). This facilitates the degradation and recycling of macromolecules, including proteins, nucleic acids, carbohydrates, and lipids, with the resulting metabolites exported to the cell through dedicated permeases. The transport into lysosomes of material from both intracellular and extracellular sources for degradation and recycling is allowed by the fusion of lysosomes with autophagosomes or LEs. Lysosomes also establish physical interactions with most of the others intracellular compartments through MCS. For instance, MCS between endolysosomes and the ER are mediated by the ER transmembrane protein SNX19 and the phosphoinositide PI(3)P located on the endolysosomal membrane. Lysosomes are also recognized as central hubs that sense nutrients and nucleic acids and from which different signaling pathways can be activated. Among the well-characterized autophagy regulators, the mTORC1 stands out as a master regulator of cell growth and metabolism. Under normal conditions, mTORC1 is activated on the lysosomal membrane (Dibble and Cantley, 2015) and negatively regulates autophagosome formation. However, during amino acid and glucose starvation, mTORC1 moves out of the lysosomes and become inactive (Son et al., 2019, 2020, 2024). This prevents the inhibition of the ULK1 complex and promotes autophagy (Hosokawa et al., 2009; Russell et al., 2013). The dissociation of mTORC1 from lysosomes also plays a critical role in the activation of a specific transcriptional program controlled by the transcription factor TFEB. In conditions associated to starvation or lysosome dysfunction, TFEB is translocated to the nucleus and binds to the CLEAR (coordinated lysosomal expression and regulation) motif presents on the promotor region of many genes encoding lysosomal enzymes and membrane proteins (Medina et al., 2011; Spampanato et al., 2013). Although lysosomes are distributed throughout the cytoplasm, they are mainly concentrated in the perinuclear area. Lysosome positioning and dynamics are orchestrated by transport along the microtubules, with the anterograde transport of lysosome from the perinuclear area to the cell periphery mediated by kinesin motor proteins. Once relocated to the cell periphery, lysosomes can fuse with the PM and release their content into the extracellular space. Lysosomal exocytosis is ensured by the mobilization of a specific fusion machinery and is triggered by an increase in intracellular Ca²⁺ concentration. Overall, while lysosomes are primarily known for their degradative function, in response to intrinsic demands, external cues, and environmental changes, lysosomal properties can be finely regulated and adapted, cooperating to convert lysosomes into secretory compartments. BORC, BLOC-1-related complex; HOPS, homotipic fusion and vacuole protein sorting. The figure was created with Biorender.

Alzheimer's and Parkinson's diseases (Neupane et al., 2023; Dujardin et al., 2014; Clavaguera et al., 2009). The adverse consequences of material clearance via lysosomal exocytosis are also amplified by the dissemination of toxic misfolded proteins between neighboring cells through the transport of lysosomes via tunneling nanotubes (Dilsizoglu Senol et al., 2021; Abounit et al., 2016). Overall, this suggests that targeting molecular players involved in lysosome transport and exocytosis holds promise for the treatment of neurodegenerative diseases, although the development and validation of such strategies require in vivo models that faithfully recapitulate the dynamic spatiotemporal progression of lesions observed in patients.

In conclusion, there is no doubt that research in lysosome biology will unveil key mechanisms of intercellular communication and enhance our understanding of various disease conditions.

## Acknowledgments

J. Villeneuve acknowledges support from the Centre National de la Recherche Scientifique, the Institut National pour la Santé et la Recherche Médicale, the University of Montpellier, the Fondation Vaincre Alzheimer, the Association France Alzheimer et maladies apparentées, the Association France Parkinson, the Fédération pour la Recherche sur le Cerveau, and the Agence Nationale de la Recherche (ANR-23-CE16-0012). M. Chiritoiu-Butnaru acknowledges support by the Romanian Academy for a Core Program and a research grant (155/GAR2023). S.E. Stewart acknowledges support from the Australian Research Council. M.-L. Parmentier acknowledges support from the Centre of Excellence in Neurodegeneration. D.C. Rubinsztein's work is supported by the UK Dementia Research Institute through UK DRI Ltd, principally funded by the UK Medical Research Council, and the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre at Addenbrooke's Hospital. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health and Social Care.

Author contributions: E. Néel: Writing—review & editing, M. Chiritoiu-Butnaru: Writing—original draft, Writing—review & editing, W. Fargues: Writing—review & editing, M. Denus: Writing—review & editing, M. Colladant: Writing—review & editing, S.E. Stewart: Conceptualization, Funding acquisition, Writing—original draft, Writing—review & editing, S. Lehmann: Funding acquisition, Writing—review & editing, C. Zurzolo: Conceptualization, Writing—review & editing, D.C. Rubinsztein: Funding acquisition, Writing—original draft, Writing—review & editing, P. Marin: Writing—review & editing, M.-L. Parmentier: Conceptualization, Visualization, Writing—original draft, Writing—review & editing, J. Villeneuve: Conceptualization, Supervision, Visualization, Writing—original draft, Writing—review & editing.

Disclosures: D.C. Rubinsztein reported grants from UK Dementia Research Institute and National Institute for Health Research Cambridge Biomedical Research Centre at Addenbrooke's Hospital during the conduct of the study; and personal fees from consulting for Drishti Discoveries, PAQ Therapeutics, MindRank AI, Nido Biosciences, Retro Biosciences, and Alexion Pharma International Operations Limited outside the submitted work. No other disclosures were reported.

Submitted: 2 May 2024

Revised: 12 July 2024

Accepted: 26 July 2024

## References

* Abounit, S., L. Bousset, F. Loria, S. Zhu, F. de Chaumont, L. Pieri, J.-C. Olivo-Marin, R. Melki, and C. Zurzolo. 2016. Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes. *EMBO J.* 35:2120–2138. https://doi.org/10.15252/embj.201593411

* Ahat, E., S. Bui, J. Zhang, F. da Veiga Leprevost, L. Sharkey, W. Reid, A.I. Nesvizhskii, H.L. Paulson, and Y. Wang. 2022. GRASP55 regulates the unconventional secretion and aggregation of mutant huntingtin. *J. Biol. Chem.* 298:102219. https://doi.org/10.1016/j.jbc.2022.102219

* Alvarez-Erviti, L., Y. Seow, A.H. Schapira, C. Gardiner, I.L. Sargent, M.J.A. Wood, and J.M. Cooper. 2011. Lysosomal dysfunction increases exosome-mediated
<figure><img src="image_7.png" /></figure>

alpha-synuclein release and transmission. *Neurobiol. Dis.* 42:360-367.
https://doi.org/10.1016/j.nbd.2011.01.029

Andrei, C., C. Dazzi, L. Lotti, M.R. Torrisi, G. Chimini, and A. Rubartelli. 1999. The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles. *Mol. Biol. Cell.* 10:1463-1475.
https://doi.org/10.1091/mbc.10.5.1463

Andrews, N.W. 2000. Regulated secretion of conventional lysosomes. *Trends Cell Biol.* 10:316-321. https://doi.org/10.1016/S0962-8924(00)01794-3

Atakpa, P., N.B. Thillaiappan, S. Mataragka, D.L. Prole, and C.W. Taylor. 2018. IP₃ receptors preferentially associate with ER-lysosome contact sites and selectively deliver Ca²⁺ to lysosomes. *Cell Rep.* 25:3180-3193.e7.
https://doi.org/10.1016/j.celrep.2018.11.064

Bae, E.-J., M. Choi, J.T. Kim, D.-K. Kim, M.K. Jung, C. Kim, T.-K. Kim, J.S. Lee, B.C. Jung, S.J. Shin, et al. 2022. TNF-α promotes α-synuclein propagation through stimulation of senescence-associated lysosomal exocytosis. *Exp. Mol. Med.* 54:788-800. https://doi.org/10.1038/s12276-022-00789-x

Baixauli, F., C. López-Otín, and M. Mittelbrunn. 2014. Exosomes and autophagy: Coordinated mechanisms for the maintenance of cellular fitness. *Front. Immunol.* 5:403. https://doi.org/10.3389/fimmu.2014.00403

Balderhaar, H.J., and C. Ungermann. 2013. CORVET and HOPS tethering complexes: Coordinators of endosome and lysosome fusion. *J. Cell Sci.* 126:1307-1316. https://doi.org/10.1242/jcs.107805

Ballabio, A., and J.S. Bonifacino. 2020. Lysosomes as dynamic regulators of cell and organismal homeostasis. *Nat. Rev. Mol. Cell Biol.* 21:101-118.
https://doi.org/10.1038/s41580-019-0185-4

Bandyopadhyay, U., S. Sridhar, S. Kaushik, R. Kiffin, and A.M. Cuervo. 2010. Identification of regulators of chaperone-mediated autophagy. *Mol. Cell.* 39:535-547. https://doi.org/10.1016/j.molcel.2010.08.004

Banerjee, P., X. Tan, W.K. Russell, and J.M. Kurie. 2023. Analysis of Golgi secretory functions in cancer. *Methods Mol. Biol.* 2557:785-810. https://doi.org/10.1007/978-1-0716-2639-9_47

Bassaganyas, L., S.J. Popa, M. Horlbeck, C. Puri, S.E. Stewart, F. Campelo, A. Ashok, C.M. Butnaru, N. Brouwers, K. Heydari, et al. 2019. New factors for protein transport identified by a genome-wide CRISPRi screen in mammalian cells. *J. Cell Biol.* 218:3861-3879. https://doi.org/10.1083/jcb.201902028

Bauerfeind, R., and W.B. Huttner. 1993. Biogenesis of constitutive secretory vesicles, secretory granules and synaptic vesicles. *Curr. Opin. Cell Biol.* 5: 628-635. https://doi.org/10.1016/0955-0674(93)90132-A

Bento, C.F., M. Renna, G. Ghislat, C. Puri, A. Ashkenazi, M. Vicinanza, F.M. Menzies, and D.C. Rubinsztein. 2016. Mammalian autophagy: How does it work? *Annu. Rev. Biochem.* 85:685-713. https://doi.org/10.1146/annurev-biochem-060815-014556

Bian, B., S. Mongrain, S. Cagnol, M.J. Langlois, J. Boulanger, G. Bernatchez, J.C. Carrier, F. Boudreau, and N. Rivard. 2016. Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasis. *Mol. Carcinog.* 55:671-687. https://doi.org/10.1002/mc.22312

Blott, E.J., and G.M. Griffiths. 2002. Secretory lysosomes. *Nat. Rev. Mol. Cell Biol.* 3:122-131. https://doi.org/10.1038/nrm732

Bonifacino, J.S. 2004. Insights into the biogenesis of lysosome-related organelles from the study of the Hermansky-Pudlak syndrome. *Ann. N. Y. Acad. Sci.* 1038:103-114. https://doi.org/10.1196/annals.1315.018

Bossard, C., D. Bresson, R.S. Polishchuk, and V. Malhotra. 2007. Dimeric PKD regulates membrane fission to form transport carriers at the TGN. *J. Cell Biol.* 179:1123-1131. https://doi.org/10.1083/jcb.200703166

Bowman, S.L., J. Bi-Karchin, L. Le, and M.S. Marks. 2019. The road to lysosome-related organelles: Insights from Hermansky-Pudlak syndrome and other rare diseases. *Traffic.* 20:404-435. https://doi.org/10.1111/tra.12646

Braun, M., A. Waheed, and K. von Figura. 1989. Lysosomal acid phosphatase is transported to lysosomes via the cell surface. *EMBO J.* 8:3633-3640.
https://doi.org/10.1002/j.1460-2075.1989.tb08537.x

Bright, N.A., L.J. Davis, and J.P. Luzio. 2016. Endolysosomes are the principal intracellular sites of acid hydrolase activity. *Curr. Biol.* 26:2233-2245.
https://doi.org/10.1016/j.cub.2016.06.046

Bright, N.A., B.J. Reaves, B.M. Mullock, and J.P. Luzio. 1997. Dense core lysosomes can fuse with late endosomes and are re-formed from the resultant hybrid organelles. *J. Cell Sci.* 110:2027-2040. https://doi.org/10.1242/jcs.110.17.2027

Brown, J.A., E.K. Novak, and R.T. Swank. 1985. Effects of ammonia on processing and secretion of precursor and mature lysosomal enzyme from macrophages of normal and pale ear mice: Evidence for two distinct pathways. *J. Cell Biol.* 100:1894-1904. https://doi.org/10.1083/jcb.100.6.1894

Bruns, C., J.M. McCaffery, A.J. Curwin, J.M. Duran, and V. Malhotra. 2011. Biogenesis of a novel compartment for autophagosome-mediated

unconventional protein secretion. *J. Cell Biol.* 195:979-992. https://doi.org/10.1083/jcb.201106098

Buratta, S., B. Tancini, K. Sagini, F. Delo, E. Chiaradia, L. Urbanelli, and C. Emiliani. 2020. Lysosomal exocytosis, exosome release and secretory autophagy: The autophagic- and endo-lysosomal systems go extracel- lular. *Int. J. Mol. Sci.* 21:2576. https://doi.org/10.3390/ijms21072576

Burgoyne, R.D., and A. Morgan. 2003. Secretory granule exocytosis. *Physiol. Rev.* 83:581-632. https://doi.org/10.1152/physrev.00031.2002

Burkhardt, J.K., C.J. Echeverri, T. Nilsson, and R.B. Vallee. 1997. Over-expression of the dynamitin (p50) subunit of the dynactin complex disrupts dynein-dependent maintenance of membrane organelles dis- tribution. *J. Cell Biol.* 139:469-484. https://doi.org/10.1083/jcb.139.2.469

Cao, H., M. Sekiya, M.E. Ertunc, M.F. Burak, J.R. Mayers, A. White, K. Inouye, L.M. Rickey, B.C. Ercal, M. Furuhashi, et al. 2013. Adipocyte lipid cha- perone AP2 is a secreted adipokine regulating hepatic glucose produc- tion. *Cell Metab.* 17:768-778. https://doi.org/10.1016/j.cmet.2013.04.012

Cashikar, A.G., and P.I. Hanson. 2019. A cell-based assay for CD63-containing extracellular vesicles. *PLoS One.* 14:e0220007. https://doi.org/10.1371/journal.pone.0220007

Castro-Gomes, T., M. Corrotte, C. Tam, and N.W. Andrews. 2016. Plasma membrane repair is regulated extracellularly by proteases released from lysosomes. *PLoS One.* 11:e0152583. https://doi.org/10.1371/journal.pone.0152583

Chapel, A., S. Kieffer-Jaquinod, C. Sagné, Q. Verdon, C. Ivaldi, M. Mellal, J. Thirion, M. Jadot, C. Bruley, J. Garin, et al. 2013. An extended proteome map of the lysosomal membrane reveals novel potential transporters. *Mol. Cell. Proteomics.* 12:1572-1588. https://doi.org/10.1074/mcp.M112.021980

Chen, D., Y.G. Zhao, and H. Zhang. 2022. Endomembrane remodeling in SARS-CoV-2 infection. *Cell Insight.* 1:100031. https://doi.org/10.1016/j.cellin.2022.100031

Chen, Y., D.C. Gershlick, S.Y. Park, and J.S. Bonifacino. 2017. Segregation in the Golgi complex precedes export of endolysosomal proteins in distinct transport carriers. *J. Cell Biol.* 216:4141-4151. https://doi.org/10.1083/jcb.201707172

Chiang, H.L., S.R. Terlecky, C.P. Plant, and J.F. Dice. 1989. A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. *Science.* 246:382-385. https://doi.org/10.1126/science.2799391

Chiritoiu, M., N. Brouwers, G. Turacchio, M. Pirozzi, and V. Malhotra. 2019. GRASP55 and UPR control interleukin-1β aggregation and secretion. *Dev. Cell.* 49:145-155.e4. https://doi.org/10.1016/j.devcel.2019.02.011

Chiritoiu-Butnaru, M., S.E. Stewart, M. Zhang, V. Malhotra, and J. Ville- neuve. 2022. Editorial: Unconventional protein secretion: From basic mechanisms to dysregulation in disease. *Front. Cell Dev. Biol.* 10: 1088002. https://doi.org/10.3389/fcell.2022.1088002

Cisneros, J., T.B. Belton, G.C. Shum, C.G. Molakal, and Y.C. Wong. 2022. Mitochondria-lysosome contact site dynamics and misregulation in neurodegenerative diseases. *Trends Neurosci.* 45:312-322. https://doi.org/10.1016/j.tins.2022.01.005

Clavaguera, F., T. Bolmont, R.A. Crowther, D. Abramowski, S. Frank, A. Probst, G. Fraser, A.K. Stalder, M. Beibel, M. Staufenbiel, et al. 2009. Transmission and spreading of tauopathy in transgenic mouse brain. *Nat. Cell Biol.* 11:909-913. https://doi.org/10.1038/ncb1901

Cruz-Garcia, D., A.J. Curwin, J.F. Popoff, C. Bruns, J.M. Duran, and V. Mal- hotra. 2014. Remodeling of secretory compartments creates CUPS during nutrient starvation. *J. Cell Biol.* 207:695-703. https://doi.org/10.1083/jcb.201407119

Curwin, A.J., N. Brouwers, M. Alonso Y Adell, D. Teis, G. Turacchio, S. Par- ashuraman, P. Ronchi, and V. Malhotra. 2016. ESCRT-III drives the final stages of CUPS maturation for unconventional protein secretion. *Elife.* 5:e16299. https://doi.org/10.7554/eLife.16299

Davis, C.W., and B.F. Dickey. 2008. Regulated airway goblet cell mucin secretion. *Annu. Rev. Physiol.* 70:487-512. https://doi.org/10.1146/annurev-physiol.70.113006.100638

de Chadarévian, J.P. 2011. Renal giant cytoplasmic inclusions in Chédiak-Higashi syndrome: First ultrastructural demonstration in a human biopsy. *Ultrastruct. Pathol.* 35:172-175. https://doi.org/10.3109/01913123.2011.584656

De Matteis, M.A., and A. Luini. 2008. Exiting the Golgi complex. *Nat. Rev. Mol. Cell Biol.* 9:273-284. https://doi.org/10.1038/nrm2378

Dell'Angelica, E.C., C. Mullins, S. Caplan, and J.S. Bonifacino. 2000. Lysosome-related organelles. *FASEB J.* 14:1265-1278. https://doi.org/10.1096/fasebj.14.10.1265

Deretic, V., S. Jiang, and N. Dupont. 2012. Autophagy intersections with conventional and unconventional secretion in tissue development,
remodeling and inflammation. *Trends Cell Biol.* 22:397-406. https://doi.org/10.1016/j.tcb.2012.04.008

DeSelm, C.J., B.C. Miller, W. Zou, W.L. Beatty, E. van Meel, Y. Takahata, J. Klumperman, S.A. Tooze, S.L. Teitelbaum, and H.W. Virgin. 2011. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. *Dev. Cell.* 21:966-974. https://doi.org/10.1016/j.devcel.2011.08.016

Dibble, C.C., and L.C. Cantley. 2015. Regulation of mTORC1 by PI3K signaling. *Trends Cell Biol.* 25:545-555. https://doi.org/10.1016/j.tcb.2015.06.002

Dice, J.F. 1990. Peptide sequences that target cytosolic proteins for lysosomal proteolysis. *Trends Biochem. Sci.* 15:305-309. https://doi.org/10.1016/0968-0004(90)90019-8

Dilsizoglu Senol, A., M. Samarani, S. Syan, C.M. Guardia, T. Nonaka, N. Liv, P. Latour-Lambert, M. Hasegawa, J. Klumperman, J.S. Bonifacino, and C. Zurzolo. 2021. α-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes. *PLoS Biol.* 19:e3001287. https://doi.org/10.1371/journal.pbio.3001287

Dimond, R.L., R.A. Burns, and K.B. Jordan. 1981. Secretion of Lysosomal enzymes in the cellular slime mold, Dictyostelium discoideum. *J. Biol. Chem.* 256:6565-6572. https://doi.org/10.1016/S0021-9258(19)69026-5

Dujardin, S., K. Lécolle, R. Caillierez, S. Bégard, N. Sommer, C. Lachaud, S. Carrier, N. Dufour, G. Aurégan, J. Winderickx, et al. 2014. Neuron-to-neuron wild-type tau protein transfer through a trans-synaptic mechanism: Relevance to sporadic tauopathies. *Acta Neuropathol. Commun.* 2: 14. https://doi.org/10.1186/2051-5960-2-14

Dupont, N., S. Jiang, M. Pilli, W. Ornatowski, D. Bhattacharya, and V. Deretic. 2011. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. *EMBO J.* 30:4701-4711. https://doi.org/10.1038/embj.2011.398

Duran, J.M., C. Anjard, C. Stefan, W.F. Loomis, and V. Malhotra. 2010. Unconventional secretion of Acbl is mediated by autophagosomes. *J. Cell Biol.* 188:527-536. https://doi.org/10.1083/jcb.200911154

Durchfort, N., S. Verhoef, M.B. Vaughn, R. Shrestha, D. Adam, J. Kaplan, and D.M. Ward. 2012. The enlarged lysosomes in beige j cells result from decreased lysosome fission and not increased lysosome fusion. *Traffic.* 13:108-119. https://doi.org/10.1111/j.1600-0854.2011.01300.x

Ejlerskov, P., I. Rasmussen, T.T. Nielsen, A.-L. Bergström, Y. Tohyama, P.H. Jensen, and F. Vilhardt. 2013. Tubulin polymerization-promoting protein (TPPP/p25α) promotes unconventional secretion of α-synuclein through exophagy by impairing autophagosome-lysosome fusion. *J. Biol. Chem.* 288:17313-17335. https://doi.org/10.1074/jbc.M112.401174

Evavold, C.L., J. Ruan, Y. Tan, S. Xia, H. Wu, and J.C. Kagan. 2018. The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. *Immunity.* 48:35-44.e6. https://doi.org/10.1016/j.immuni.2017.11.013

Filaquier, A., P. Marin, M.-L. Parmentier, and J. Villeneuve. 2022. Roads and hubs of unconventional protein secretion. *Curr. Opin. Cell Biol.* 75: 102072. https://doi.org/10.1016/j.ceb.2022.02.006

Fleming, A., M. Bourdenx, M. Fujimaki, C. Karabiyik, G.J. Krause, A. Lopez, A. Martín-Segura, C. Puri, A. Scrivo, J. Skidmore, et al. 2022. The different autophagy degradation pathways and neurodegeneration. *Neuron.* 110: 935-966. https://doi.org/10.1016/j.neuron.2022.01.017

Fontaine, S.N., D. Zheng, J.J. Sabbagh, M.D. Martin, D. Chaput, A. Darling, J.H. Trotter, A.R. Stothert, B.A. Nordhues, A. Lussier, et al. 2016. DnaJ/Hsc70 chaperone complexes control the extracellular release of neurodegenerative-associated proteins. *EMBO J.* 35:1537-1549. https://doi.org/10.15252/embj.201593489

Frankel, E.B., and A. Audhya. 2018. ESCRT-dependent cargo sorting at multivesicular endosomes. *Semin. Cell Dev. Biol.* 74:4-10. https://doi.org/10.1016/j.semcdb.2017.08.020

Frasa, M.A.M., F.C. Maximiano, K. Smolarczyk, R.E. Francis, M.E. Betson, E. Lozano, J. Goldenring, M.C. Seabra, A. Rak, M.R. Ahmadian, and V.M.M. Braga. 2010. Armus is a Rac1 effector that inactivates Rab7 and regulates E-cadherin degradation. *Curr. Biol.* 20:198-208. https://doi.org/10.1016/j.cub.2009.12.053

Funato, Y., A. Yoshida, Y. Hirata, O. Hashizume, D. Yamazaki, and H. Miki. 2020. The oncogenic PRL protein causes acid addiction of cells by stimulating lysosomal exocytosis. *Dev. Cell.* 55:387-397.e8. https://doi.org/10.1016/j.devcel.2020.08.009

Ge, L., D. Melville, M. Zhang, and R. Schekman. 2013. The ER-Golgi intermediate compartment is a key membrane source for the LC3 lipidation step of autophagosome biogenesis. *Elife.* 2:e00947. https://doi.org/10.7554/eLife.00947

Ge, L., M. Zhang, S.J. Kenny, D. Liu, M. Maeda, K. Saito, A. Mathur, K. Xu, and R. Schekman. 2017. Remodeling of ER-exit sites initiates a membrane

supply pathway for autophagosome biogenesis. *EMBO Rep.* 18:1586-1603. https://doi.org/10.15252/embr.201744599

Ge, L., M. Zhang, and R. Schekman. 2014. Phosphatidylinositol 3-kinase and COPII generate LC3 lipidation vesicles from the ER-Golgi intermediate compartment. *Elife.* 3:e04135. https://doi.org/10.7554/eLife.04135

Gee, H.Y., J. Kim, and M.G. Lee. 2018. Unconventional secretion of trans-membrane proteins. *Semin. Cell Dev. Biol.* 83:59-66. https://doi.org/10.1016/j.semcdb.2018.03.016

Gerstenmaier, L., R. Pilla, L. Herrmann, H. Herrmann, M. Prado, G.J. Villafano, M. Kolonko, R. Reimer, T. Soldati, J.S. King, and M. Hagedorn. 2015. The autophagic machinery ensures nonlytic transmission of mycobacteria. *Proc. Natl. Acad. Sci. USA.* 112:E687-E692. https://doi.org/10.1073/pnas.1423318112

Gottlieb, M., and D.M. Dwyer. 1981. Protozoan parasite of humans: Surface membrane with externally disposed acid phosphatase. *Science.* 212: 939-941. https://doi.org/10.1126/science.7233189

Gross, S.K., T.B. Shea, and R.H. McCluer. 1985. Altered secretion and accumulation of kidney glycosphingolipids by mouse pigmentation mutants with lysosomal dysfunctions. *J. Biol. Chem.* 260:5033-5039. https://doi.org/10.1016/S0021-9258(18)89175-X

Hämäläistö, S., F. Del Valle Batalla, M.I. Yuseff, and P.K. Mattila. 2024. Endolysosomal vesicles at the center of B cell activation. *J. Cell Biol.* 223: e202307047. https://doi.org/10.1083/jcb.202307047

Harding, C.V. 1996. Class II antigen processing: Analysis of compartments and functions. *Crit. Rev. Immunol.* 16:13-29. https://doi.org/10.1615/critrevimmunol.v16.i1.20

Hilgemann, D.W., M. Fine, M.E. Linder, B.C. Jennings, and M.J. Lin. 2013. Massive endocytosis triggered by surface membrane palmitoylation under mitochondrial control in BHK fibroblasts. *Elife.* 2:e01293. https://doi.org/10.7554/eLife.01293

Hirokawa, N., and Y. Noda. 2008. Intracellular transport and kinesin superfamily proteins, KIFs: Structure, function, and dynamics. *Physiol. Rev.* 88:1089-1118. https://doi.org/10.1152/physrev.00023.2007

Holcomb, C.L., W.J. Hansen, T. Etcheverry, and R. Schekman. 1988. Secretory vesicles externalize the major plasma membrane ATPase in yeast. *J. Cell Biol.* 106:641-648. https://doi.org/10.1083/jcb.106.3.641

Hosokawa, N., T. Hara, T. Kaizuka, C. Kishi, A. Takamura, Y. Miura, S. Iemura, T. Natsume, K. Takehana, N. Yamada, et al. 2009. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. *Mol. Biol. Cell.* 20:1981-1991. https://doi.org/10.1091/mbc.e08-12-1248

Huotari, J., and A. Helenius. 2011. Endosome maturation. *EMBO J.* 30: 3481-3500. https://doi.org/10.1038/emboj.2011.286

Jaiswal, J.K., N.W. Andrews, and S.M. Simon. 2002. Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. *J. Cell Biol.* 159:625-635. https://doi.org/10.1083/jcb.200208154

Jeppesen, D.K., A.M. Fenix, J.L. Franklin, J.N. Higginbotham, Q. Zhang, L.J. Zimmerman, D.C. Liebler, J. Ping, Q. Liu, R. Evans, et al. 2019. Reassessment of exosome composition. *Cell.* 177:428-445.e18. https://doi.org/10.1016/j.cell.2019.02.029

Jiao, M., C. Wang, X. Tang, C. Dai, N. Zhang, A. Fan, Z. Qian, S. Liu, F. Zhang, B. Li, et al. 2024. Active secretion of IL-33 from astrocytes is dependent on TMED10 and promotes central nervous system homeostasis. *Brain Behav. Immun.* 119:539-553. https://doi.org/10.1016/j.bbi.2024.04.028

Jin, Y., B.S. Strunk, and L.S. Weisman. 2015. Close encounters of the lysosome-peroxisome kind. *Cell.* 161:197-198. https://doi.org/10.1016/j.cell.2015.03.046

Johansson, M., N. Rocha, W. Zwart, I. Jordens, L. Janssen, C. Kuijl, V.M. Olkkonen, and J. Neefjes. 2007. Activation of endosomal dynein motors by stepwise assembly of Rab7-RILP-p150Gluved, ORPIL, and the receptor betall spectrin. *J. Cell Biol.* 176:459-471. https://doi.org/10.1083/jcb.200606077

Johnson, D.E., P. Ostrowski, V. Jaumouillé, and S. Grinstein. 2016. The position of lysosomes within the cell determines their luminal pH. *J. Cell Biol.* 212:677-692. https://doi.org/10.1083/jcb.201507112

Jongsma, M.L.M., I. Berlin, R.H.M. Wijdeven, L. Janssen, G.M.C. Janssen, M.A. Garstka, H. Janssen, M. Mensink, P.A. van Veelen, R.M. Spaapen, and J. Neefjes. 2016. An ER-associated pathway defines endosomal architecture for controlled cargo transport. *Cell.* 166:152-166. https://doi.org/10.1016/j.cell.2016.05.078

Kaushik, S., and A.M. Cuervo. 2016. AMPK-dependent phosphorylation of lipid droplet protein PLIN2 triggers its degradation by CMA. *Autophagy.* 12:432-438. https://doi.org/10.1080/15548627.2015.1124226
Kaushik, S., and A.M. Cuervo. 2018. The coming of age of chaperone-mediated autophagy. *Nat. Rev. Mol. Cell Biol.* 19:365-381. https://doi.org/10.1038/s41580-018-0001-6

Kim, M.S., S. Muallem, S.H. Kim, K.B. Kwon, and M.S. Kim. 2019. Exosomal release through TRPML1-mediated lysosomal exocytosis is required for adipogenesis. *Biochem. Biophys. Res. Commun.* 510:409-415. https://doi.org/10.1016/j.bbrc.2019.01.115

Kimura, T., J. Jia, S. Kumar, S.W. Choi, Y. Gu, M. Mudd, N. Dupont, S. Jiang, R. Peters, F. Farzam, et al. 2017. Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy. *EMBO J.* 36:42-60. https://doi.org/10.15252/embj.201695081

Kjeldsen, L., D.F. Bainton, H. Sengeløv, and N. Borregaard. 1993. Structural and functional heterogeneity among peroxidase-negative granules in human neutrophils: Identification of a distinct gelatinase-containing granule subset by combined immunocytochemistry and subcellular fractionation. *Blood.* 82:3183-3191. https://doi.org/10.1182/blood.v82.10.3183.bloodjournal82103183

Klumperman, J., and G. Raposo. 2014. The complex ultrastructure of the endolysosomal system. *Cold Spring Harb. Perspect. Biol.* 6:a016857. https://doi.org/10.1101/cshperspect.a016857

Korolchuk, V.I., S. Saiki, M. Lichtenberg, F.H. Siddiqi, E.A. Roberts, S. Imarisio, L. Jahreiss, S. Sarkar, M. Futter, F.M. Menzies, et al. 2011. Lysosomal positioning coordinates cellular nutrient responses. *Nat. Cell Biol.* 13:453-460. https://doi.org/10.1038/ncb2204

Kumar, N., M. Leonzino, W. Hancock-Cerutti, F.A. Horenkamp, P. Li, J.A. Lees, H. Wheeler, K.M. Reinisch, and P. De Camilli. 2018. VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. *J. Cell Biol.* 217:3625-3639. https://doi.org/10.1083/jcb.201807019

Lee, J., Y. Xu, L. Saidi, M. Xu, K. Zinsmaier, and Y. Ye. 2023. Abnormal triaging of misfolded proteins by adult neuronal ceroid lipofuscinosis-associated DNAJC5/CSPα mutants causes lipofuscin accumulation. *Autophagy.* 19:204-223. https://doi.org/10.1080/15548627.2022.2065618

Lee, J., Y. Xu, and Y. Ye. 2022. Safeguarding lysosomal homeostasis by DNAJC5/CSPα-mediated unconventional protein secretion and endosomal microautophagy. *Front. Cell Dev. Biol.* 10:906453. https://doi.org/10.3389/fcell.2022.906453

Lee, J., Y. Xu, T. Zhang, L. Cui, L. Saidi, and Y. Ye. 2018. Secretion of misfolded cytosolic proteins from mammalian cells is independent of chaperone-mediated autophagy. *J. Biol. Chem.* 293:14359-14370. https://doi.org/10.1074/jbc.RA118.003660

Lee, J.G., S. Takahama, G. Zhang, S.I. Tomarev, and Y. Ye. 2016. Unconventional secretion of misfolded proteins promotes adaptation to proteasome dysfunction in mammalian cells. *Nat. Cell Biol.* 18:765-776. https://doi.org/10.1038/ncb3372

Leisten, E.D., A.C. Woods, and Y.C. Wong. 2023. Super-resolution microscopy: Insights into mitochondria-lysosome crosstalk in health and disease. *J. Cell Biol.* 222:e202305032. https://doi.org/10.1083/jcb.202305032

LeSage, G.D., W.E. Robertson, and M.A. Baumgart. 1993. Bile acid-dependent vesicular transport of lysosomal enzymes into bile in the rat. *Gastroenterology.* 105:889-900. https://doi.org/10.1016/0016-5085(93)90909-V

Levine, B., and G. Kroemer. 2019. Biological functions of autophagy genes: A disease perspective. *Cell.* 176:11-42. https://doi.org/10.1016/j.cell.2018.09.048

Li, S., R. Yan, J. Xu, S. Zhao, X. Ma, Q. Sun, M. Zhang, Y. Li, J.G. Liu, L. Chen, et al. 2022. A new type of ERGIC-ERES membrane contact mediated by TMED9 and SEC12 is required for autophagosome biogenesis. *Cell Res.* 32:119-138. https://doi.org/10.1038/s41422-021-00563-0

Liu, D.-A., K. Tao, B. Wu, Z. Yu, M. Szczepaniak, M. Rames, C. Yang, T. Svitkina, Y. Zhu, F. Xu, et al. 2023. A phosphoinositide switch mediates exocyst recruitment to multivesicular endosomes for exosome secretion. *Nat. Commun.* 14:6883. https://doi.org/10.1038/s41467-023-42661-0

Lunghi, G., E.V. Carsana, N. Loberto, L. Cioccarelli, S. Prioni, L. Mauri, R. Bassi, S. Duga, L. Straniero, R. Asselta, et al. 2022. β-Glucocerebrosidase deficiency activates an aberrant lysosome-plasma membrane Axis responsible for the onset of neurodegeneration. *Cells.* 11:2343. https://doi.org/10.3390/cells11152343

Luo, D.X., M.C. Huang, J. Ma, Z. Gao, D.F. Liao, and D. Cao. 2011. Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway. *Biochem. J.* 438:71-80. https://doi.org/10.1042/BJ2011011

Luo, J., L. Jiang, H. Yang, and B.-L. Song. 2017. Routes and mechanisms of post-endosomal cholesterol trafficking: A story that never ends. *Traffic.* 18:209-217. https://doi.org/10.1111/tra.12471

Luzio, J.P., Y. Hackmann, N.M.G. Dieckmann, and G.M. Griffiths. 2014. The biogenesis of lysosomes and lysosome-related organelles. *Cold Spring

Harb. Perspect. Biol. 6:a016840. https://doi.org/10.1101/cshperspect.a016840

Mambula, S.S., and S.K. Calderwood. 2006. Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. *J. Immunol.* 177:7849-7857. https://doi.org/10.4049/jimmunol.177.11.7849

Martina, J.A., Y. Chen, M. Gucek, and R. Puertollano. 2012. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. *Autophagy.* 8:903-914. https://doi.org/10.4161/auto.19653

Martinez, I., S. Chakrabarti, T. Hellevik, J. Morehead, K. Fowler, and N.W. Andrews. 2000. Synaptotagmin VII regulates Ca(2+)-dependent exocytosis of lysosomes in fibroblasts. *J. Cell Biol.* 148:1141-1149. https://doi.org/10.1083/jcb.148.6.1141

Medina, D.L., A. Fraldi, V. Bouche, F. Annunziata, G. Mansueto, C. Spampanato, C. Puri, A. Pignata, J.A. Martina, M. Sardiello, et al. 2011. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. *Dev. Cell.* 21:421-430. https://doi.org/10.1016/j.devcel.2011.07.016

Meldolesi, J. 2022. Unconventional protein secretion dependent on two extracellular vesicles: Exosomes and ectosomes. *Front. Cell Dev. Biol.* 10:877344. https://doi.org/10.3389/fcell.2022.877344

Miao, Y., G. Li, X. Zhang, H. Xu, and S.N. Abraham. 2015. A TRP channel senses lysosome neutralization by pathogens to trigger their expulsion. *Cell.* 161:1306-1319. https://doi.org/10.1016/j.cell.2015.05.009

Mostov, K., and Z. Werb. 1997. Journey across the osteoclast. *Science.* 276:219-220. https://doi.org/10.1126/science.276.5310.219

Müller, M. 1972. Secretion of acid hydrolases and its intracellular source in Tetrahymena pyriformis. *J. Cell Biol.* 52:478-487. https://doi.org/10.1083/jcb.52.2.478

Neupane, S., E. De Cecco, and A. Aguzzi. 2023. The hidden cell-to-cell trail of α-synuclein aggregates. *J. Mol. Biol.* 435:167930. https://doi.org/10.1016/j.jmb.2022.167930

New, J., and S.M. Thomas. 2019. Autophagy-dependent secretion: Mechanism, factors secreted, and disease implications. *Autophagy.* 15:1682-1693. https://doi.org/10.1080/15548627.2019.1596479

Nordmann, M., M. Cabrera, A. Perz, C. Bröcker, C. Ostrowicz, S. Engelbrecht-Vandré, and C. Ungermann. 2010. The Mon1-Ccz1 complex is the GEF of the late endosomal Rab7 homolog Ypt7. *Curr. Biol.* 20:1654-1659. https://doi.org/10.1016/j.cub.2010.08.002

Orlow, S.J. 1995. Melanosomes are specialized members of the lysosomal lineage of organelles. *J. Invest. Dermatol.* 105:3-7. https://doi.org/10.1111/1523-1747.ep12312291

Parchure, A., and J. von Blume. 2023. Sorting secretory proteins. *Elife.* 12:e93490. https://doi.org/10.7554/eLife.93490

Perera, R.M., and R. Zoncu. 2016. The lysosome as a regulatory hub. *Annu. Rev. Cell Dev. Biol.* 32:223-253. https://doi.org/10.1146/annurev-cellbio-111315-125125

Piovesana, E., C. Magrin, M. Ciccaldo, M. Sola, M. Bellotto, M. Molinari, S. Papin, and P. Paganetti. 2023. Tau accumulation in degradative organelles is associated to lysosomal stress. *Sci. Rep.* 13:18024. https://doi.org/10.1038/s41598-023-44979-7

Platt, F.M., A. d'Azzo, B.L. Davidson, E.F. Neufeld, and C.J. Tiftt. 2018. Lysosomal storage diseases. *Nat. Rev. Dis. Primers.* 4:27. https://doi.org/10.1038/s41572-018-0025-4

Polishchuk, R.S., E. San Pietro, A. Di Pentima, S. Teté, and J.S. Bonifacino. 2006. Ultrastructure of long-range transport carriers moving from the trans Golgi network to peripheral endosomes. *Traffic.* 7:1092-1103. https://doi.org/10.1111/j.1600-0854.2006.00453.x

Popa, S., J. Villeneuve, S. Stewart, E. Perez Garcia, A. Petrunkina Harrison, and K. Moreau. 2019. Genome-wide CRISPR screening identifies new regulators of glycoprotein secretion. *Wellcome Open Res.* 4:119. https://doi.org/10.12688/wellcomeopenres.15232.1

Progida, C., L. Malerød, S. Stuffers, A. Brech, C. Bucci, and H. Stenmark. 2007. RILP is required for the proper morphology and function of late endosomes. *J. Cell Sci.* 120:3729-3737. https://doi.org/10.1242/jcs.017301

Proux-Gillardeaux, V., G. Raposo, T. Irinopoulou, and T. Galli. 2007. Expression of the Longin domain of TI-VAMP impairs lysosomal secretion and epithelial cell migration. *Biol. Cell.* 99:261-271. https://doi.org/10.1042/BC20060097

Pu, J., C.M. Guardia, T. Keren-Kaplan, and J.S. Bonifacino. 2016. Mechanisms and functions of lysosome positioning. *J. Cell Sci.* 129:4329-4339. https://doi.org/10.1042/jcs.196287

Pu, J., C. Schindler, R. Jia, M. Jarnik, P. Backlund, and J.S. Bonifacino. 2015. BORC, a multisubunit complex that regulates lysosome positioning. *Dev. Cell.* 33:176-188. https://doi.org/10.1016/j.devcel.2015.02.011
Quintavalle, C., S. Di Costanzo, C. Zanca, I. Tasset, A. Fraldi, M. Incoronato, P. Mirabelli, M. Monti, A. Ballabio, P. Pucci, et al. 2014. Phosphorylation-regulated degradation of the tumor-suppressor form of PED by chaperone-mediated autophagy in lung cancer cells. *J. Cell. Physiol.* **229**: 1359-1368. https://doi.org/10.1002/jcp.24569

Rabouille, C. 2017. Pathways of unconventional protein secretion. *Trends Cell Biol.* **27**:230-240. https://doi.org/10.1016/j.tcb.2016.11.007

Rabouille, C., V. Malhotra, and W. Nickel. 2012. Diversity in unconventional protein secretion. *J. Cell Sci.* **125**:5251-5255. https://doi.org/10.1242/jcs.103630

Radisky, D.C., M. Stallings-Mann, Y. Hirai, and M.J. Bissell. 2009. Single proteins might have dual but related functions in intracellular and extracellular microenvironments. *Nat. Rev. Mol. Cell Biol.* **10**:228-234. https://doi.org/10.1038/nrm2633

Raiborg, C., E.M. Wenzel, N.M. Pedersen, H. Olsvik, K.O. Schink, S.W. Schultz, M. Vietri, V. Nisi, C. Bucci, A. Brech, et al. 2015. Repeated ER-endosome contacts promote endosome translocation and neurite outgrowth. *Nature*. **520**:234-238. https://doi.org/10.1038/nature14359

Rao, S.K., C. Huynh, V. Proux-Gillardeaux, T. Galli, and N.W. Andrews. 2004. Identification of SNAREs involved in synaptotagmin VII-regulated lysosomal exocytosis. *J. Biol. Chem.* **279**:20471-20479. https://doi.org/10.1074/jbc.M400798200

Rapoport, T.A. 2007. Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes. *Nature*. **450**:663-669. https://doi.org/10.1038/nature06384

Raposo, G., M.S. Marks, and D.F. Cutler. 2007. Lysosome-related organelles: Driving post-Golgi compartments into specialisation. *Curr. Opin. Cell Biol.* **19**:394-401. https://doi.org/10.1016/j.ceb.2007.05.001

Reddy, A., E.V. Caler, and N.W. Andrews. 2001. Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes. *Cell*. **106**:157-169. https://doi.org/10.1016/S0092-8674(01)00421-4

Remec Pavlin, M., and J.H. Hurley. 2020. The ESCRTs - converging on mechanism. *J. Cell Sci.* **133**:jcs240333. https://doi.org/10.1242/jcs.240333

Rocha, N., C. Kuijl, R. van der Kant, L. Janssen, D. Houben, H. Janssen, W. Zwart, and J. Neefjes. 2009. Cholesterol sensor ORPIL contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioning. *J. Cell Biol.* **185**:1209-1225. https://doi.org/10.1083/jcb.200811005

Rocznik-Ferguson, A., C.S. Petit, F. Froehlich, S. Qian, J. Ky, B. Angarola, T.C. Walther, and S.M. Ferguson. 2012. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. *Sci. Signal.* **5**:ra42. https://doi.org/10.1126/scisignal.2002790

Rodríguez, A., P. Webster, J. Ortego, and N.W. Andrews. 1997. Lysosomes behave as Ca²⁺-regulated exocytic vesicles in fibroblasts and epithelial cells. *J. Cell Biol.* **137**:93-104. https://doi.org/10.1083/jcb.137.1.93

Roney, J.C., X.-T. Cheng, and Z.-H. Sheng. 2022. Neuronal endolysosomal transport and lysosomal functionality in maintaining axonostasis. *J. Cell Biol.* **221**:e202111077. https://doi.org/10.1083/jcb.202111077

Rose, K., T. Jepson, S. Shukla, A. Maya-Romero, M. Kampmann, K. Xu, and J.H. Hurley. 2023. Tau fibrils induce nanoscale membrane damage and nucleate cytosolic tau at lysosomes. *bioRxiv*. https://doi.org/10.1101/2023.08.28.555157 (Preprint posted August 28, 2023).

Russell, R.C., Y. Tian, H. Yuan, H.W. Park, Y.Y. Chang, J. Kim, H. Kim, T.P. Neufeld, A. Dillin, and K.L. Guan. 2013. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. *Nat. Cell Biol.* **15**:741-750. https://doi.org/10.1083/ncb2757

Saric, A., S.A. Freeman, C.D. Williamson, M. Jarnik, C.M. Guardia, M.S. Fernandopulle, D.C. Gershlick, and J.S. Bonifacino. 2021. SNX19 restricts endolysosome motility through contacts with the endoplasmic reticulum. *Nat. Commun.* **12**:4552. https://doi.org/10.1038/s41467-021-24709-1

Schekman, R.W. 2008. Retrospective: George E. Palade (1912-2008). *Science*. **322**:695. https://doi.org/10.1126/science.1167174

Schuchman, E.H. 2010. Acid sphingomyelinase, cell membranes and human disease: Lessons from niemann-pick disease. *FEBS Lett.* **584**:1895-1900. https://doi.org/10.1016/j.febset.2009.11.083

Schwartz, L.B., and K.F. Austen. 1980. Enzymes of the mast cell granule. *J. Invest. Dermatol.* **74**:349-353. https://doi.org/10.1111/1523-1747.ep12543620

Semino, C., S. Carta, M. Gattorno, R. Sitia, and A. Rubartelli. 2018. Progressive waves of IL-1β release by primary human monocytes via sequential activation of vesicular and gasdermin D-mediated secretory pathways. *Cell Death Dis.* **9**:1088. https://doi.org/10.1038/s41419-018-1121-9

Settembre, C., C. Di Malta, V.A. Polito, M. Garcia Arencibia, F. Vetrini, S. Erdin, S.U. Erdin, T. Huynh, D. Medina, P. Colella, et al. 2011. TFEB links autophagy to lysosomal biogenesis. *Science*. **332**:1429-1433. https://doi.org/10.1126/science.1204592

Settembre, C., R. Zoncu, D.L. Medina, F. Vetrini, S. Erdin, S. Erdin, T. Huynh, M. Ferron, G. Karsenty, M.C. Vellard, et al. 2012. A lysosome-to-nucleus

signalling mechanism senses and regulates the lysosome via mTOR and TFEB. *EMBO J.* **31**:1095-1108. https://doi.org/10.1038/emboj.2012.32

Sevenich, L., and J.A. Joyce. 2014. Pericellular proteolysis in cancer. *Genes Dev.* **28**:2331-2347. https://doi.org/10.1101/gad.250647.114

Sitia, R., and A. Rubartelli. 2020. Evolution, role in inflammation, and redox control of leaderless secretory proteins. *J. Biol. Chem.* **295**:7799-7811. https://doi.org/10.1074/jbc.rev119.008907

Son, S.M., S.J. Park, S.Y. Breusegem, D. Larrieu, and D.C. Rubinsztein. 2024. p300 nucleocytoplasmic shuttling underlies mTORC1 hyperactivation in Hutchinson-Gilford progeria syndrome. *Nat. Cell Biol.* **26**:235-249. https://doi.org/10.1038/s41556-023-01338-y

Son, S.M., S.J. Park, H. Lee, F. Siddiqi, J.E. Lee, F.M. Menzies, and D.C. Rubinsztein. 2019. Leucine signals to mTORC1 via its metabolite acetyl-coenzyme A. *Cell Metab.* **29**:192-201.e7. https://doi.org/10.1016/j.cmet.2018.08.013

Son, S.M., S.J. Park, E. Stamatakou, M. Vicinanza, F.M. Menzies, and D.C. Rubinsztein. 2020. Leucine regulates autophagy via acetylation of the mTORC1 component raptor. *Nat. Commun.* **11**:3148. https://doi.org/10.1038/s41467-020-16886-2

Spampanato, C., E. Feeney, L. Li, M. Cardone, J.-A. Lim, F. Annunziata, H. Zare, R. Polishchuk, R. Puertollano, G. Parenti, et al. 2013. Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. *EMBO Mol. Med.* **5**:691-706. https://doi.org/10.1002/emmm.201202176

Stalder, D., and D.C. Gershlick. 2020. Direct trafficking pathways from the Golgi apparatus to the plasma membrane. *Semin. Cell Dev. Biol.* **10**:112-125. https://doi.org/10.1016/j.semcdb.2020.04.001

Starling, G.P., Y.Y. Yip, A. Sanger, P.E. Morton, E.R. Eden, and M.P. Dodding. 2016. Folliculin directs the formation of a Rab34-RILP complex to control the nutrient-dependent dynamic distribution of lysosomes. *EMBO Rep.* **17**:823-841. https://doi.org/10.15252/embr.201541382

Steringer, J.P., S. Lange, S. Čujová, R. Sachl, C. Poojari, F. Lolicato, O. Beutel, H.-M. Müller, U. Unger, Ü. Coskun, et al. 2017. Key steps in unconventional secretion of fibroblast growth factor 2 reconstituted with purified components. *Elife*. **6**:e28985. https://doi.org/10.7554/efla.28985

Sun, Y., X. Tao, Y. Han, X. Lin, R. Tian, H. Wang, P. Chang, Q. Sun, L. Ge, and M. Zhang. 2024. A dual role of ERGIC-localized Rabs in TMED10-mediated unconventional protein secretion. *Nat. Cell Biol.* **26**:1077-1092. https://doi.org/10.1038/s41556-024-01445-4

Takenouchi, T., M. Nakai, Y. Iwamaru, S. Sugama, M. Tsukimoto, M. Fujita, J. Wei, A. Sekigawa, M. Sato, S. Kojima, et al. 2009. The activation of P2X7 receptor impairs lysosomal functions and stimulates the release of autophagolysosomes in microglial cells. *J. Immunol.* **182**:2051-2062. https://doi.org/10.4049/jimmunol.0802577

Takla, M., S. Keshri, and D.C. Rubinsztein. 2023. The post-translational regulation of transcription factor EB (TFEB) in health and disease. *EMBO Rep.* **24**:e57574. https://doi.org/10.15252/embr.202357574

Tam, C., V. Idone, C. Devlin, M.C. Fernandes, A. Flannery, X. He, E. Schuchman, I. Tabas, and N.W. Andrews. 2010. Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair. *J. Cell Biol.* **189**:1027-1038. https://doi.org/10.1083/jcb.201003053

Tancini, B., S. Buratta, F. Delo, K. Sagini, E. Chiaradia, R.M. Pellegrino, C. Emiliani, and L. Urbanelli. 2020. Lysosomal exocytosis: The extracellular role of an intracellular organelle. *Membranes.* **10**:406. https://doi.org/10.3390/membranes10120406

Tang, Z., C. Xia, R. Huang, X. Li, W.C. Wang, W. Guo, L. Duan, W. Luo, D. Cao, and D.X. Luo. 2014. Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway. *Int. J. Clin. Exp. Pathol.* **7**:3791-3799.

Tapper, H., and R. Sundler. 1995. Bafilomycin A1 inhibits lysosomal, phagosomal, and plasma membrane H(+)-ATPase and induces lysosomal enzyme secretion in macrophages. *J. Cell. Physiol.* **163**:137-144. https://doi.org/10.1002/jcp.1041630116

Tsunemi, T., T. Perez-Rosello, Y. Ishiguro, A. Yoroisaka, S. Jeon, K. Hamada, M. Rammonhan, Y.C. Wong, Z. Xie, W. Akamatsu, et al. 2019. Increased lysosomal exocytosis induced by lysosomal Ca²⁺ channel agonists protects human dopaminergic neurons from α-synuclein toxicity. *J. Neurosci.* **39**:5760-5772. https://doi.org/10.1523/JNEUROSCI.3085-18.2019

Ushio, H., T. Ueno, Y. Kojima, M. Komatsu, S. Tanaka, A. Yamamoto, Y. Ichimura, J. Ezaki, K. Nishida, S. Komazawa-Sakon, et al. 2011. Crucial role for autophagy in degranulation of mast cells. *J. Allergy Clin. Immunol.* **127**:1267-1276.e6. https://doi.org/10.1016/j.jaci.2010.12.1078

Van Oost, B.A., J.B. Smith, H. Holmsen, and G.D. Vladutiu. 1985. Lysosomal agents selectively potentiate thrombin-induced acid hydrolase
secretion from platelets. *Proc. Natl. Acad. Sci. USA.* 82:2374-2378.
https://doi.org/10.1073/pnas.82.8.2374

Vieira, O.V. 2018. Rab3a and Rab10 are regulators of lysosome exocytosis and plasma membrane repair. *Small GTPases*. 9:349-351. https://doi.org/10.1080/21541248.2016.1235004

Villeneuve, J., L. Bassaganyas, S. Lepreux, M. Chiritoiu, P. Costet, J. Ripoche, V. Malhotra, and R. Schekman. 2018. Unconventional secretion of FABP4 by endosomes and secretory lysosomes. *J. Cell Biol.* 217:649-665.
https://doi.org/10.1083/jcb.201705047

Walkley, S.U., and M.T. Vanier. 2009. Secondary lipid accumulation in lysosomal disease. *Biochim. Biophys. Acta.* 1793:726-736. https://doi.org/10.1016/j.bbamcr.2008.11.014

Wang, Y., M. Huang, X. Mu, W. Song, Q. Guo, M. Zhang, Y. Liu, Y.-G. Chen, and L. Ge. 2024. TMED10-mediated unconventional secretion of IL-33 regulates intestinal epithelium differentiation and homeostasis. *Cell Res.* 34:258-261. https://doi.org/10.1038/s41422-023-00891-3

Wu, S., N.C. Hernandez Villegas, D.W. Sirkis, I. Thomas-Wright, R. Wade-Martins, and R. Schekman. 2023. Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers. *Elife*. 12:e85837. https://doi.org/10.7554/eLife.85837

Xu, Y., L. Cui, A. Dibello, L. Wang, J. Lee, L. Saidi, J.-G. Lee, and Y. Ye. 2018. DNAJC5 facilitates USP19-dependent unconventional secretion of misfolded cytosolic proteins. *Cell Discov.* 4:11. https://doi.org/10.1038/s41421-018-0012-7

Xu, Y., S. Du, J.A. Marsh, K. Horie, C. Sato, A. Ballabio, C.M. Karch, D.M. Holtzman, and H. Zheng. 2020. TFEB regulates lysosomal exocytosis of tau and its loss of function exacerbates tau pathology and spreading. *Mol. Psychiatry*. 26:5925-5939. https://doi.org/10.1038/s41380-020-0738-0

Yang, C., and X. Wang. 2021. Lysosome biogenesis: Regulation and functions. *J. Cell Biol.* 220:e202102001. https://doi.org/10.1083/jcb.202102001

Ye, Y. 2018. Regulation of protein homeostasis by unconventional protein secretion in mammalian cells. *Semin. Cell Dev. Biol.* 83:29-35. https://doi.org/10.1016/j.semcdb.2018.03.006

Yogalingam, G., E.J. Bonten, D. van de Vlekkert, H. Hu, S. Moshiach, S.A. Connell, and A. d'Azzo. 2008. Neuraminidase 1 is a negative regulator of lysosomal exocytosis. *Dev. Cell*. 15:74-86. https://doi.org/10.1016/j.devcel.2008.05.005

Zeitler, M., J.P. Steringer, H.-M. Müller, M.P. Mayer, and W. Nickel. 2015. HIV-tat protein forms phosphoinositide-dependent membrane pores implicated in unconventional protein secretion. *J. Biol. Chem.* 290: 21976-21984. https://doi.org/10.1074/jbc.M115.667097

Zhang, M., S.J. Kenny, L. Ge, K. Xu, and R. Schekman. 2015. Translocation of interleukin-1β into a vesicle intermediate in autophagy-mediated secretion. *Elife*. 4:e11205. https://doi.org/10.7554/eLife.11205

Zhang, M., L. Liu, X. Lin, Y. Wang, Y. Li, Q. Guo, S. Li, Y. Sun, X. Tao, D. Zhang, et al. 2020. A translocation pathway for vesicle-mediated unconventional protein secretion. *Cell*. 181:637-652.e15. https://doi.org/10.1016/j.cell.2020.03.031

Zhang, M., and R. Schekman. 2013. Cell biology. Unconventional secretion, unconventional solutions. *Science*. 340:559-561. https://doi.org/10.1126/science.1234740

Zhang, X.-M., B. Walsh, C.A. Mitchell, and T. Rowe. 2005. TBC domain family, member 15 is a novel mammalian Rab GTPase-activating protein with substrate preference for Rab7. *Biochem. Biophys. Res. Commun.* 335: 154-161. https://doi.org/10.1016/j.bbrc.2005.07.070

Zhou, D., P. Li, Y. Lin, J.M. Lott, A.D. Hislop, D.H. Canaday, R.R. Brutkiewicz, and J.S. Blum. 2005. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. *Immunity*. 22:571-581. https://doi.org/10.1016/j.immuni.2005.03.009

Zoncu, R., and R.M. Perera. 2022. Built to last: Lysosome remodeling and repair in health and disease. *Trends Cell Biol.* 32:597-610. https://doi.org/10.1016/j.tcb.2021.12.009